Live Cell Imaging Market by Product (Instruments, Consumables, Software, Services), Application (Cell Biology, Stem Cells, Drug Discovery), Technology (Time-lapse Microscopy, FRET, FRAP, HCS), End User (Pharma, Biotech, CROs) - Global Forecast to 2028
The global live cell imaging market is projected to reach USD 4.3 billion by 2028 from USD 2.7 billion in 2023, at a CAGR of 10.2% during the forecast period of 2023 to 2028. The growth of this market can be attributed to the high/growing adoption of high-content screening techniques in drug discovery. As drug discovery becomes increasingly reliant on high-throughput screening and HCS techniques, the demand for live cell imaging technology is likely to grow. This trend is expected to be particularly pronounced in the field of personalized medicine, where live cell imaging can be used to identify treatments tailored to individual patients.
“The consumables segment accounted for the second-largest share by product & service during the forecast period”
In 2022, consumables segment accounted for the second-largest share by product & service in the global live cell imaging market. Consumables include a range of products that are used in the imaging and analysis of live cells. These consumables play an important role in the live cell imaging workflow, as they are essential for sample preparation, maintenance, and analysis. Consumables used in live cell imaging include reagents, media, assay kits, and other consumables such as microplates, slides, Petri dishes, coverslips, and culture chambers. Consumables are typically disposable and need to be replenished regularly, making them an important recurring revenue stream for manufacturers. Consumables are an integral part of live cell imaging, and growth in this segment is mainly driven by the increasing demand for advanced imaging technologies and the growing adoption of live cell analysis in various research applications.
“Europe: The second largest region in the live cell imaging market”
Europe accounted for the second-largest market for live cell imaging after North America. The European live cell imaging market has witnessed significant growth in recent years, driven by various factors that have propelled its expansion. Europe is at the forefront of developing and adopting emerging technologies in the field of live cell imaging. This includes advancements in super-resolution microscopy, high-throughput imaging, single-cell imaging, and multi-modal imaging approaches. The adoption of these innovative technologies accelerates the progress of live cell imaging research and expands its applications. Additionally, Europe offers comprehensive training and education programs in live cell imaging techniques. Universities, research institutes, and organizations provide specialized courses, workshops, and conferences to enhance the knowledge and skills of scientists and researchers. The availability of training programs promotes the adoption and utilization of live cell imaging technologies in Europe.
The primary interviews conducted for this report can be categorized as follows:
This report provides a detailed picture of the live cell imaging market. It aims at estimating the size and future growth potential of the market across different segments such as the product & service, application, technology, end user and region. The report also includes an in-depth competitive analysis of the key market players along with their company profiles recent developments and key market strategies.
Key Benefits of Buying the Report:
The report will help market leaders/new entrants by providing them with the closest approximations of the revenue numbers for the overall market and its subsegments. It will also help stakeholders better understand the competitive landscape and gain more insights to better position their business and make suitable go-to-market strategies. This report will enable stakeholders to understand the market's pulse and provide them with information on the key market drivers, restraints, opportunities, and challenges
The report provides insights on the following pointers:
“The consumables segment accounted for the second-largest share by product & service during the forecast period”
In 2022, consumables segment accounted for the second-largest share by product & service in the global live cell imaging market. Consumables include a range of products that are used in the imaging and analysis of live cells. These consumables play an important role in the live cell imaging workflow, as they are essential for sample preparation, maintenance, and analysis. Consumables used in live cell imaging include reagents, media, assay kits, and other consumables such as microplates, slides, Petri dishes, coverslips, and culture chambers. Consumables are typically disposable and need to be replenished regularly, making them an important recurring revenue stream for manufacturers. Consumables are an integral part of live cell imaging, and growth in this segment is mainly driven by the increasing demand for advanced imaging technologies and the growing adoption of live cell analysis in various research applications.
“Europe: The second largest region in the live cell imaging market”
Europe accounted for the second-largest market for live cell imaging after North America. The European live cell imaging market has witnessed significant growth in recent years, driven by various factors that have propelled its expansion. Europe is at the forefront of developing and adopting emerging technologies in the field of live cell imaging. This includes advancements in super-resolution microscopy, high-throughput imaging, single-cell imaging, and multi-modal imaging approaches. The adoption of these innovative technologies accelerates the progress of live cell imaging research and expands its applications. Additionally, Europe offers comprehensive training and education programs in live cell imaging techniques. Universities, research institutes, and organizations provide specialized courses, workshops, and conferences to enhance the knowledge and skills of scientists and researchers. The availability of training programs promotes the adoption and utilization of live cell imaging technologies in Europe.
The primary interviews conducted for this report can be categorized as follows:
- By Respondent: Supply Side- 80% and Demand Side 20%
- By Designation: C-level - 45%, D-level - 30%, and Others - 25%
- By Region: North America -20%, Europe -10%, Asia-Pacific -55%, Latin America -10%, Middle East & Africa- 5%
- Danaher (US)
- ZEISS Group (Germany)
- Nikon Corporation (Japan)
- Olympus Corporation (Japan)
- PerkinElmer Inc. (US)
- Sartorius AG (Germany)
- Agilent Technologies, Inc. (US)
- Thermo Fisher Scientific, Inc. (US)
- Etaluma, Inc. (US)
- CytoSMART Technologies (Netherlands)
- NanoEnTek Inc. (South Korea)
- GE Healthcare (US)
- Bruker Corporation (US)
- Becton, Dickinson and Company (BD) (US)
- Merck KGaA (Germany)
- Bio-Rad Laboratories, Inc. (US)
- Blue-Ray Biotech Corp. (Taiwan)
- CYTENA GmbH (Germany)
- Nanolive SA (Switzerland)
- Abberior (Germany)
- Phase Holographic Imaging (PHI) AB (Sweden)
- Cytoskeleton, Inc. (US)
- Corning Incorporated (US)
- KEYENCE Corporation (Japan)
- Aligned Genetics, Inc. (South Korea)
This report provides a detailed picture of the live cell imaging market. It aims at estimating the size and future growth potential of the market across different segments such as the product & service, application, technology, end user and region. The report also includes an in-depth competitive analysis of the key market players along with their company profiles recent developments and key market strategies.
Key Benefits of Buying the Report:
The report will help market leaders/new entrants by providing them with the closest approximations of the revenue numbers for the overall market and its subsegments. It will also help stakeholders better understand the competitive landscape and gain more insights to better position their business and make suitable go-to-market strategies. This report will enable stakeholders to understand the market's pulse and provide them with information on the key market drivers, restraints, opportunities, and challenges
The report provides insights on the following pointers:
- Analysis of key drivers (growing adoption of high-content screening techniques in drug discovery, rising incidence of cancer, and growing availability of funds for research), restraints (High cost of high-content screening systems), opportunities (increasing adoption of live cell imaging technologies in emerging markets, and application of HCS in personalized medicine), and challenges (maintaining cell viability and cellular environment in cell cultures, and image analysis and data management) influencing the growth of the market.
- Product and Service Development/Innovation: Detailed insights on newly launched products & services, and technological assessment of the live cell imaging market
- Market Development: Comprehensive information about lucrative markets - the report analyses the market across varied regions.
- Market Diversification: Exhaustive information about new products and services, untapped geographies, recent developments, and investments in the live cell imaging market
- Competitive Assessment: In-depth assessment of market shares, growth strategies and products and service offerings of leading players like Danaher (US), ZEISS Group (Germany), Nikon Corporation (Japan), Olympus Corporation (Japan), PerkinElmer Inc. (US), Sartorius AG (Germany), Agilent Technologies, Inc. (US), Thermo Fisher Scientific, Inc. (US), Etaluma, Inc. (US), CytoSMART Technologies (Netherlands), NanoEnTek Inc. (South Korea), GE Healthcare (US), Bruker Corporation (US), Becton, Dickinson and Company (BD) (US), Merck KGaA (Germany), Bio-Rad Laboratories, Inc. (US), Blue-Ray Biotech Corp. (Taiwan), CYTENA GmbH (Germany), Nanolive SA (Switzerland), Abberior (Germany), Phase Holographic Imaging (PHI) AB (Sweden), Cytoskeleton, Inc. (US), Corning Incorporated (US), KEYENCE Corporation (Japan), Aligned Genetics, Inc. (South Korea), and among others in the market.
1 INTRODUCTION
1.1 STUDY OBJECTIVES
1.2 MARKET DEFINITION
1.2.1 INCLUSIONS & EXCLUSIONS
1.3 MARKET SCOPE
FIGURE 1 LIVE CELL IMAGING MARKET SEGMENTATION
1.3.1 YEARS CONSIDERED
1.4 CURRENCY
1.5 LIMITATIONS
1.6 STAKEHOLDERS
1.7 SUMMARY OF CHANGES
1.7.1 RECESSION IMPACT
2 RESEARCH METHODOLOGY
2.1 RESEARCH DATA
FIGURE 2 RESEARCH DESIGN
2.1.1 SECONDARY DATA
2.1.2 PRIMARY DATA
FIGURE 3 LIVE CELL IMAGING MARKET: BREAKDOWN OF PRIMARIES
2.2 MARKET SIZE ESTIMATION
FIGURE 4 MARKET SIZE ESTIMATION: SUPPLY-SIDE ANALYSIS, 2022
FIGURE 5 MARKET SIZE ESTIMATION: APPROACH 1 (REVENUE SHARE ANALYSIS), 2022
FIGURE 6 ILLUSTRATIVE EXAMPLE OF DANAHER CORPORATION: REVENUE SHARE ANALYSIS, 2022
2.2.1 INSIGHTS FROM PRIMARIES
FIGURE 7 MARKET VALIDATION FROM PRIMARY EXPERTS
FIGURE 8 MARKET SIZE ESTIMATION METHODOLOGY: TOP-DOWN APPROACH
2.3 GROWTH FORECAST
FIGURE 9 LIVE CELL IMAGING MARKET: CAGR PROJECTIONS, 2022–2028
FIGURE 10 LIVE CELL IMAGING MARKET: GROWTH ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
2.4 MARKET BREAKDOWN AND DATA TRIANGULATION
FIGURE 11 DATA TRIANGULATION METHODOLOGY
2.5 RESEARCH ASSUMPTIONS
2.6 RISK ANALYSIS
2.7 RECESSION IMPACT ON LIVE CELL IMAGING MARKET
TABLE 1 GLOBAL INFLATION RATE PROJECTIONS, 2021–2027 (% GROWTH)
TABLE 2 US HEALTH EXPENDITURE, 2019–2022 (USD MILLION)
TABLE 3 US HEALTH EXPENDITURE, 2023–2027 (USD MILLION)
3 EXECUTIVE SUMMARY
FIGURE 12 LIVE CELL IMAGING MARKET, BY PRODUCT & SERVICE, 2023 VS. 2028 (USD MILLION)
FIGURE 13 LIVE CELL IMAGING MARKET, BY APPLICATION, 2023 VS. 2028 (USD MILLION)
FIGURE 14 LIVE CELL IMAGING MARKET, BY TECHNOLOGY, 2023 VS. 2028 (USD MILLION)
FIGURE 15 LIVE CELL IMAGING MARKET, BY END USER, 2023 VS. 2028 (USD MILLION)
FIGURE 16 GEOGRAPHICAL SNAPSHOT OF LIVE CELL IMAGING MARKET
4 PREMIUM INSIGHTS
4.1 LIVE CELL IMAGING MARKET OVERVIEW
FIGURE 17 GROWING ADOPTION OF HIGH-CONTENT SCREENING TECHNIQUES IN DRUG DISCOVERY TO DRIVE MARKET GROWTH
4.2 NORTH AMERICA: LIVE CELL IMAGING MARKET SHARE, BY PRODUCT & SERVICE AND COUNTRY (2022)
FIGURE 18 INSTRUMENTS DOMINATED NORTH AMERICAN LIVE CELL IMAGING MARKET IN 2022
4.3 LIVE CELL IMAGING MARKET, BY PRODUCT & SERVICE, 2023 VS. 2028 (USD MILLION)
FIGURE 19 INSTRUMENTS TO CONTINUE TO DOMINATE MARKET BY 2028
4.4 LIVE CELL IMAGING MARKET SHARE, BY END USER, 2022
FIGURE 20 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES ACCOUNTED FOR LARGEST MARKET SHARE IN 2022
4.5 LIVE CELL IMAGING MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES
FIGURE 21 ASIA PACIFIC TO REGISTER HIGHEST GROWTH RATE IN LIVE CELL IMAGING MARKET FROM 2023 TO 2028
5 MARKET OVERVIEW
5.1 INTRODUCTION
5.2 MARKET DYNAMICS
FIGURE 22 LIVE CELL IMAGING MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
TABLE 4 LIVE CELL IMAGING MARKET: IMPACT ANALYSIS
5.2.1 DRIVERS
5.2.1.1 Growing adoption of high-content screening techniques in drug discovery
5.2.1.2 Rising incidence of cancer
TABLE 5 ESTIMATED NEW CANCER CASES IN US, 2023
FIGURE 23 GLOBAL CANCER INCIDENCE & MORTALITY, 2020
5.2.1.3 Growing availability of research funds
TABLE 6 INVESTMENT BREAKDOWN, 2021 (USD MILLION)
5.2.2 RESTRAINTS
5.2.2.1 High cost of high-content screening systems
5.2.3 OPPORTUNITIES
5.2.3.1 Increasing adoption of live cell imaging technologies in emerging economies
5.2.3.2 Applications of HCS in personalized medicine
5.2.4 CHALLENGES
5.2.4.1 Maintaining cell viability and cellular environment in cell cultures
5.2.4.2 Image analysis and data management
5.3 TECHNOLOGY ANALYSIS
5.4 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES
FIGURE 24 REVENUE SHIFT & NEW POCKETS FOR LIVE CELL IMAGING PRODUCT & SERVICE PROVIDERS
5.5 VALUE/SUPPLY CHAIN ANALYSIS
5.5.1 VALUE CHAIN ANALYSIS
FIGURE 25 LIVE CELL IMAGING MARKET: VALUE CHAIN ANALYSIS
5.5.2 SUPPLY CHAIN ANALYSIS
FIGURE 26 LIVE CELL IMAGING MARKET: SUPPLY CHAIN ANALYSIS
5.6 REGULATORY ANALYSIS
5.6.1 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
5.6.1.1 North America
5.6.1.1.1 US
5.6.1.1.2 Canada
5.6.1.2 Europe
5.6.1.3 Asia Pacific
5.6.1.4 Rest of the World
5.7 PORTER’S FIVE FORCES ANALYSIS
TABLE 7 LIVE CELL IMAGING MARKET: PORTER’S FIVE FORCES ANALYSIS
5.7.1 THREAT OF NEW ENTRANTS
5.7.2 THREAT OF SUBSTITUTES
5.7.3 BARGAINING POWER OF SUPPLIERS
5.7.4 BARGAINING POWER OF BUYERS
5.7.5 INTENSITY OF COMPETITIVE RIVALRY
5.8 ECOSYSTEM ANALYSIS
TABLE 8 SUPPLY CHAIN ECOSYSTEM
5.9 PRICING ANALYSIS
5.9.1 AVERAGE SELLING PRICE, BY KEY PLAYER
TABLE 9 AVERAGE SELLING PRICES
5.9.2 AVERAGE SELLING PRICE TREND
5.10 KEY CONFERENCES & EVENTS IN 2022–2023
TABLE 10 LIVE CELL IMAGING: DETAILED LIST OF CONFERENCES & EVENTS
5.11 KEY STAKEHOLDERS AND BUYING CRITERIA
5.11.1 KEY STAKEHOLDERS IN BUYING PROCESS
FIGURE 27 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS OF LIVE CELL IMAGING PRODUCTS
5.11.2 BUYING CRITERIA FOR LIVE CELL IMAGING
FIGURE 28 KEY BUYING CRITERIA FOR END USERS
5.12 PATENT ANALYSIS
FIGURE 29 LIVE CELL IMAGING MARKET: PATENT APPLICATIONS (JANUARY 2020–APRIL 2023)
6 LIVE CELL IMAGING MARKET, BY PRODUCT & SERVICE
6.1 INTRODUCTION
TABLE 11 LIVE CELL IMAGING MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION)
6.2 INSTRUMENTS
TABLE 12 EXAMPLES OF INSTRUMENTS OFFERED BY MARKET PLAYERS
TABLE 13 LIVE CELL IMAGING INSTRUMENTS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 14 LIVE CELL IMAGING INSTRUMENTS MARKET, BY REGION, 2021–2028 (USD MILLION)
TABLE 15 NORTH AMERICA: LIVE CELL IMAGING INSTRUMENTS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 16 EUROPE: LIVE CELL IMAGING INSTRUMENTS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 17 ASIA PACIFIC: LIVE CELL IMAGING INSTRUMENTS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 18 LATIN AMERICA: LIVE CELL IMAGING INSTRUMENTS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
6.2.1 MICROSCOPES
6.2.1.1 Continuous technological advancements in microscopes to support market
TABLE 19 CONVENTIONAL MICROSCOPES OFFERED BY KEY MARKET PLAYERS
TABLE 20 CONFOCAL MICROSCOPES OFFERED BY KEY MARKET PLAYERS
TABLE 21 FLUORESCENCE MICROSCOPES OFFERED BY KEY MARKET PLAYERS
TABLE 22 LIVE CELL IMAGING INSTRUMENTS MARKET FOR MICROSCOPES, BY REGION, 2021–2028 (USD MILLION)
TABLE 23 NORTH AMERICA: LIVE CELL IMAGING INSTRUMENTS MARKET FOR MICROSCOPES, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 24 EUROPE: LIVE CELL IMAGING INSTRUMENTS MARKET FOR MICROSCOPES, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 25 ASIA PACIFIC: LIVE CELL IMAGING INSTRUMENTS MARKET FOR MICROSCOPES, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 26 LATIN AMERICA: LIVE CELL IMAGING INSTRUMENTS MARKET FOR MICROSCOPES, BY COUNTRY, 2021–2028 (USD MILLION)
6.2.2 STANDALONE SYSTEMS
6.2.2.1 Seamless integration and workflow efficiency of standalone systems to boost demand
TABLE 27 STANDALONE SYSTEMS OFFERED BY KEY MARKET PLAYERS
TABLE 28 LIVE CELL IMAGING INSTRUMENTS MARKET FOR STANDALONE SYSTEMS, BY REGION, 2021–2028 (USD MILLION)
TABLE 29 NORTH AMERICA: LIVE CELL IMAGING INSTRUMENTS MARKET FOR STANDALONE SYSTEMS, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 30 EUROPE: LIVE CELL IMAGING INSTRUMENTS MARKET FOR STANDALONE SYSTEMS, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 31 ASIA PACIFIC: LIVE CELL IMAGING INSTRUMENTS MARKET FOR STANDALONE SYSTEMS, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 32 LATIN AMERICA: LIVE CELL IMAGING INSTRUMENTS MARKET FOR STANDALONE SYSTEMS, BY COUNTRY, 2021–2028 (USD MILLION)
6.2.3 CELL ANALYZERS
6.2.3.1 Accuracy and reproducibility of cell analyzers to support growth
TABLE 33 CELL ANALYZERS OFFERED BY KEY MARKET PLAYERS
TABLE 34 LIVE CELL IMAGING INSTRUMENTS MARKET FOR CELL ANALYZERS, BY REGION, 2021–2028 (USD MILLION)
TABLE 35 NORTH AMERICA: LIVE CELL IMAGING INSTRUMENTS MARKET FOR CELL ANALYZERS, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 36 EUROPE: LIVE CELL IMAGING INSTRUMENTS MARKET FOR CELL ANALYZERS, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 37 ASIA PACIFIC: LIVE CELL IMAGING INSTRUMENTS MARKET FOR CELL ANALYZERS, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 38 LATIN AMERICA: LIVE CELL IMAGING INSTRUMENTS MARKET FOR CELL ANALYZERS, BY COUNTRY, 2021–2028 (USD MILLION)
6.2.4 ACCESSORIES
6.2.4.1 Ability of accessories to optimize and enhance imaging conditions to boost demand
TABLE 39 ACCESSORIES OFFERED BY KEY MARKET PLAYERS
TABLE 40 LIVE CELL IMAGING INSTRUMENTS MARKET FOR ACCESSORIES, BY REGION, 2021–2028 (USD MILLION)
TABLE 41 NORTH AMERICA: LIVE CELL IMAGING INSTRUMENTS MARKET FOR ACCESSORIES, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 42 EUROPE: LIVE CELL IMAGING INSTRUMENTS MARKET FOR ACCESSORIES, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 43 ASIA PACIFIC: LIVE CELL IMAGING INSTRUMENTS MARKET FOR ACCESSORIES, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 44 LATIN AMERICA: LIVE CELL IMAGING INSTRUMENTS MARKET FOR ACCESSORIES, BY COUNTRY, 2021–2028 (USD MILLION)
6.3 CONSUMABLES
TABLE 45 LIVE CELL IMAGING CONSUMABLES MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 46 LIVE CELL IMAGING CONSUMABLES MARKET, BY REGION, 2021–2028 (USD MILLION)
TABLE 47 NORTH AMERICA: LIVE CELL IMAGING CONSUMABLES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 48 EUROPE: LIVE CELL IMAGING CONSUMABLES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 49 ASIA PACIFIC: LIVE CELL IMAGING CONSUMABLES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 50 LATIN AMERICA: LIVE CELL IMAGING CONSUMABLES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
6.3.1 REAGENTS
6.3.1.1 Widespread usage in life science research to fuel market growth
TABLE 51 REAGENTS OFFERED BY KEY MARKET PLAYERS
TABLE 52 LIVE CELL IMAGING CONSUMABLES MARKET FOR REAGENTS, BY REGION, 2021–2028 (USD MILLION)
TABLE 53 NORTH AMERICA: LIVE CELL IMAGING CONSUMABLES MARKET FOR REAGENTS, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 54 EUROPE: LIVE CELL IMAGING CONSUMABLES MARKET FOR REAGENTS, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 55 ASIA PACIFIC: LIVE CELL IMAGING CONSUMABLES MARKET FOR REAGENTS, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 56 LATIN AMERICA: LIVE CELL IMAGING CONSUMABLES MARKET FOR REAGENTS, BY COUNTRY, 2021–2028 (USD MILLION)
6.3.2 ASSAY KITS
6.3.2.1 Repeat purchase of assay kits to drive market
TABLE 57 ASSAY KITS OFFERED BY KEY MARKET PLAYERS
TABLE 58 LIVE CELL IMAGING CONSUMABLES MARKET FOR ASSAY KITS, BY REGION, 2021–2028 (USD MILLION)
TABLE 59 NORTH AMERICA: LIVE CELL IMAGING CONSUMABLES MARKET FOR ASSAY KITS, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 60 EUROPE: LIVE CELL IMAGING CONSUMABLES MARKET FOR ASSAY KITS, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 61 ASIA PACIFIC: LIVE CELL IMAGING CONSUMABLES MARKET FOR ASSAY KITS, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 62 LATIN AMERICA: LIVE CELL IMAGING CONSUMABLES MARKET FOR ASSAY KITS, BY COUNTRY, 2021–2028 (USD MILLION)
6.3.3 MEDIA
6.3.3.1 Increasing demand for optimized cell culture conditions to drive demand for media
TABLE 63 MEDIA OFFERED BY KEY MARKET PLAYERS
TABLE 64 LIVE CELL IMAGING CONSUMABLES MARKET FOR MEDIA, BY REGION, 2021–2028 (USD MILLION)
TABLE 65 NORTH AMERICA: LIVE CELL IMAGING CONSUMABLES MARKET FOR MEDIA, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 66 EUROPE: LIVE CELL IMAGING CONSUMABLES MARKET FOR MEDIA, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 67 ASIA PACIFIC: LIVE CELL IMAGING CONSUMABLES MARKET FOR MEDIA, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 68 LATIN AMERICA: LIVE CELL IMAGING CONSUMABLES MARKET FOR MEDIA, BY COUNTRY, 2021–2028 (USD MILLION)
6.3.4 OTHER CONSUMABLES
TABLE 69 OTHER CONSUMABLES OFFERED BY KEY MARKET PLAYERS
TABLE 70 OTHER LIVE CELL IMAGING CONSUMABLES MARKET, BY REGION, 2021–2028 (USD MILLION)
TABLE 71 NORTH AMERICA: OTHER LIVE CELL IMAGING CONSUMABLES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 72 EUROPE: OTHER LIVE CELL IMAGING CONSUMABLES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 73 ASIA PACIFIC: OTHER LIVE CELL IMAGING CONSUMABLES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 74 LATIN AMERICA: OTHER LIVE CELL IMAGING CONSUMABLES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
6.4 SOFTWARE
6.4.1 TECHNOLOGICAL ADVANCEMENTS IN IMAGE ACQUISITION TO BOOST MARKET GROWTH
TABLE 75 SOFTWARE OFFERED BY KEY MARKET PLAYERS
TABLE 76 LIVE CELL IMAGING SOFTWARE MARKET, BY REGION, 2021–2028 (USD MILLION)
TABLE 77 NORTH AMERICA: LIVE CELL IMAGING SOFTWARE MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 78 EUROPE: LIVE CELL IMAGING SOFTWARE MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 79 ASIA PACIFIC: LIVE CELL IMAGING SOFTWARE MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 80 LATIN AMERICA: LIVE CELL IMAGING SOFTWARE MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
6.5 SERVICES
6.5.1 GROWING DEMAND FOR OUTSOURCED EXPERTISE AND SPECIALIZED SERVICES TO SUPPORT MARKET
TABLE 81 LIVE CELL IMAGING SERVICES MARKET, BY REGION, 2021–2028 (USD MILLION)
TABLE 82 NORTH AMERICA: LIVE CELL IMAGING SERVICES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 83 EUROPE: LIVE CELL IMAGING SERVICES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 84 ASIA PACIFIC: LIVE CELL IMAGING SERVICES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 85 LATIN AMERICA: LIVE CELL IMAGING SERVICES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
7 LIVE CELL IMAGING MARKET, BY APPLICATION
7.1 INTRODUCTION
TABLE 86 LIVE CELL IMAGING MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
7.2 CELL BIOLOGY
TABLE 87 NUMBER OF NEW CANCER CASES, BY TYPE, 2020 VS. 2040
TABLE 88 LIVE CELL IMAGING MARKET FOR CELL BIOLOGY APPLICATIONS, BY REGION, 2021–2028 (USD MILLION)
TABLE 89 NORTH AMERICA: LIVE CELL IMAGING MARKET FOR CELL BIOLOGY APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 90 EUROPE: LIVE CELL IMAGING MARKET FOR CELL BIOLOGY APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 91 ASIA PACIFIC: LIVE CELL IMAGING MARKET FOR CELL BIOLOGY APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 92 LATIN AMERICA: LIVE CELL IMAGING MARKET FOR CELL BIOLOGY APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION)
7.3 STEM CELLS
7.3.1 GROWING FOCUS ON REGENERATIVE MEDICINE & ADVANCEMENTS IN STEM CELL RESEARCH TO BOOST MARKET
TABLE 93 LIVE CELL IMAGING MARKET FOR STEM CELL APPLICATIONS, BY REGION, 2021–2028 (USD MILLION)
TABLE 94 NORTH AMERICA: LIVE CELL IMAGING MARKET FOR STEM CELL APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 95 EUROPE: LIVE CELL IMAGING MARKET FOR STEM CELL APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 96 ASIA PACIFIC: LIVE CELL IMAGING MARKET FOR STEM CELL APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 97 LATIN AMERICA: LIVE CELL IMAGING MARKET FOR STEM CELL APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION)
7.4 DEVELOPMENTAL BIOLOGY
7.4.1 GROWING INTEREST IN UNDERSTANDING ORGANOGENESIS AND TISSUE MORPHOGENESIS TO DRIVE DEMAND
TABLE 98 LIVE CELL IMAGING MARKET FOR DEVELOPMENTAL BIOLOGY APPLICATIONS, BY REGION, 2021–2028 (USD MILLION)
TABLE 99 NORTH AMERICA: LIVE CELL IMAGING MARKET FOR DEVELOPMENTAL BIOLOGY APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 100 EUROPE: LIVE CELL IMAGING MARKET FOR DEVELOPMENTAL BIOLOGY APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 101 ASIA PACIFIC: LIVE CELL IMAGING MARKET FOR DEVELOPMENTAL BIOLOGY APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 102 LATIN AMERICA: LIVE CELL IMAGING MARKET FOR DEVELOPMENTAL BIOLOGY APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION)
7.5 DRUG DISCOVERY
7.5.1 GROWING USE OF HCS CELL-BASED ASSAYS IN DRUG DISCOVERY STUDIES TO DRIVE DEMAND
TABLE 103 LIVE CELL IMAGING MARKET FOR DRUG DISCOVERY APPLICATIONS, BY REGION, 2021–2028 (USD MILLION)
TABLE 104 NORTH AMERICA: LIVE CELL IMAGING MARKET FOR DRUG DISCOVERY APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 105 EUROPE: LIVE CELL IMAGING MARKET FOR DRUG DISCOVERY APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 106 ASIA PACIFIC: LIVE CELL IMAGING MARKET FOR DRUG DISCOVERY APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 107 LATIN AMERICA: LIVE CELL IMAGING MARKET FOR DRUG DISCOVERY APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION)
8 LIVE CELL IMAGING MARKET, BY TECHNOLOGY
8.1 INTRODUCTION
TABLE 108 LIVE CELL IMAGING MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION)
8.2 TIME-LAPSE MICROSCOPY
TABLE 109 LIVE CELL IMAGING MARKET FOR TIME-LAPSE MICROSCOPY, BY REGION, 2021–2028 (USD MILLION)
TABLE 110 NORTH AMERICA: LIVE CELL IMAGING MARKET FOR TIME-LAPSE MICROSCOPY, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 111 EUROPE: LIVE CELL IMAGING MARKET FOR TIME-LAPSE MICROSCOPY, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 112 ASIA PACIFIC: LIVE CELL IMAGING MARKET FOR TIME-LAPSE MICROSCOPY, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 113 LATIN AMERICA: LIVE CELL IMAGING MARKET FOR TIME-LAPSE MICROSCOPY, BY COUNTRY, 2021–2028 (USD MILLION)
8.3 FLUORESCENCE RESONANCE ENERGY TRANSFER (FRET)
8.3.1 ADVANCEMENTS IN FLUORESCENT MATERIALS AND PROBES TO BOOST ADOPTION OF FRET TECHNOLOGY
TABLE 114 LIVE CELL IMAGING MARKET FOR FLUORESCENCE RESONANCE ENERGY TRANSFER, BY REGION, 2021–2028 (USD MILLION)
TABLE 115 NORTH AMERICA: LIVE CELL IMAGING MARKET FOR FLUORESCENCE RESONANCE ENERGY TRANSFER, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 116 EUROPE: LIVE CELL IMAGING MARKET FOR FLUORESCENCE RESONANCE ENERGY TRANSFER, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 117 ASIA PACIFIC: LIVE CELL IMAGING MARKET FOR FLUORESCENCE RESONANCE ENERGY TRANSFER, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 118 LATIN AMERICA: LIVE CELL IMAGING MARKET FOR FLUORESCENCE RESONANCE ENERGY TRANSFER, BY COUNTRY, 2021–2028 (USD MILLION)
8.4 FLUORESCENCE RECOVERY AFTER PHOTOBLEACHING (FRAP)
8.4.1 INTEGRATION OF FRAP WITH LIVE CELL IMAGING MICROSCOPY TO CONTRIBUTE TO MARKET GROWTH
TABLE 119 LIVE CELL IMAGING MARKET FOR FLUORESCENCE RECOVERY AFTER PHOTOBLEACHING, BY REGION, 2021–2028 (USD MILLION)
TABLE 120 NORTH AMERICA: LIVE CELL IMAGING MARKET FOR FLUORESCENCE RECOVERY AFTER PHOTOBLEACHING, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 121 EUROPE: LIVE CELL IMAGING MARKET FOR FLUORESCENCE RECOVERY AFTER PHOTOBLEACHING, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 122 ASIA PACIFIC: LIVE CELL IMAGING MARKET FOR FLUORESCENCE RECOVERY AFTER PHOTOBLEACHING, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 123 LATIN AMERICA: LIVE CELL IMAGING MARKET FOR FLUORESCENCE RECOVERY AFTER PHOTOBLEACHING, BY COUNTRY, 2021–2028 (USD MILLION)
8.5 HIGH-CONTENT SCREENING (HCS)
8.5.1 GROWING ADOPTION OF HCS IN DRUG DISCOVERY AND TOXICITY SCREENING TO DRIVE GROWTH
TABLE 124 LIVE CELL IMAGING MARKET FOR HIGH-CONTENT SCREENING, BY REGION, 2021–2028 (USD MILLION)
TABLE 125 NORTH AMERICA: LIVE CELL IMAGING MARKET FOR HIGH-CONTENT SCREENING, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 126 EUROPE: LIVE CELL IMAGING MARKET FOR HIGH-CONTENT SCREENING, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 127 ASIA PACIFIC: LIVE CELL IMAGING MARKET FOR HIGH-CONTENT SCREENING, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 128 LATIN AMERICA: LIVE CELL IMAGING MARKET FOR HIGH-CONTENT SCREENING, BY COUNTRY, 2021–2028 (USD MILLION)
8.6 OTHER TECHNOLOGIES
TABLE 129 LIVE CELL IMAGING MARKET FOR OTHER TECHNOLOGIES, BY REGION, 2021–2028 (USD MILLION)
TABLE 130 NORTH AMERICA: LIVE CELL IMAGING MARKET FOR OTHER TECHNOLOGIES, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 131 EUROPE: LIVE CELL IMAGING MARKET FOR OTHER TECHNOLOGIES, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 132 ASIA PACIFIC: LIVE CELL IMAGING MARKET FOR OTHER TECHNOLOGIES, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 133 LATIN AMERICA: LIVE CELL IMAGING MARKET FOR OTHER TECHNOLOGIES, BY COUNTRY, 2021–2028 (USD MILLION)
9 LIVE CELL IMAGING MARKET, BY END USER
9.1 INTRODUCTION
TABLE 134 LIVE CELL IMAGING MARKET, BY END USER, 2021–2028 (USD MILLION)
9.2 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES
9.2.1 NEED TO ADHERE TO STRICT REGULATIONS TO DRIVE USE OF LIVE CELL IMAGING PRODUCTS AMONG PHARMA COMPANIES
TABLE 135 LIVE CELL IMAGING MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2021–2028 (USD MILLION)
TABLE 136 NORTH AMERICA: LIVE CELL IMAGING MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 137 EUROPE: LIVE CELL IMAGING MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 138 ASIA PACIFIC: LIVE CELL IMAGING MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 139 LATIN AMERICA: LIVE CELL IMAGING MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2021–2028 (USD MILLION)
9.3 ACADEMIC & RESEARCH INSTITUTES
9.3.1 INCREASING NUMBER OF DRUG DISCOVERY RESEARCH PROGRAMS TO DRIVE MARKET GROWTH
TABLE 140 LIVE CELL IMAGING MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2021–2028 (USD MILLION)
TABLE 141 NORTH AMERICA: LIVE CELL IMAGING MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 142 EUROPE: LIVE CELL IMAGING MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 143 ASIA PACIFIC: LIVE CELL IMAGING MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 144 LATIN AMERICA: LIVE CELL IMAGING MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2021–2028 (USD MILLION)
9.4 CONTRACT RESEARCH ORGANIZATIONS
9.4.1 GROWING OUTSOURCING OF R&D ACTIVITIES BY PHARMACEUTICAL COMPANIES TO DRIVE DEMAND
TABLE 145 LIVE CELL IMAGING MARKET FOR CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2021–2028 (USD MILLION)
TABLE 146 NORTH AMERICA: LIVE CELL IMAGING MARKET FOR CONTRACT RESEARCH ORGANIZATIONS, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 147 EUROPE: LIVE CELL IMAGING MARKET FOR F CONTRACT RESEARCH ORGANIZATIONS, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 148 ASIA PACIFIC: LIVE CELL IMAGING MARKET FOR CONTRACT RESEARCH ORGANIZATIONS, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 149 LATIN AMERICA: LIVE CELL IMAGING MARKET FOR CONTRACT RESEARCH ORGANIZATIONS, BY COUNTRY, 2021–2028 (USD MILLION)
10 LIVE CELL IMAGING MARKET, BY REGION
10.1 INTRODUCTION
TABLE 150 LIVE CELL IMAGING MARKET, BY REGION, 2021–2028 (USD MILLION)
10.2 NORTH AMERICA
FIGURE 30 NORTH AMERICA: LIVE CELL IMAGING MARKET SNAPSHOT
TABLE 151 NORTH AMERICA: LIVE CELL IMAGING MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 152 NORTH AMERICA: LIVE CELL IMAGING MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION)
TABLE 153 NORTH AMERICA: LIVE CELL IMAGING INSTRUMENTS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 154 NORTH AMERICA: LIVE CELL IMAGING CONSUMABLES MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 155 NORTH AMERICA: LIVE CELL IMAGING MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
TABLE 156 NORTH AMERICA: LIVE CELL IMAGING MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION)
TABLE 157 NORTH AMERICA: LIVE CELL IMAGING MARKET, BY END USER, 2021–2028 (USD MILLION)
10.2.1 US
10.2.1.1 US to dominate live cell imaging market in North America
TABLE 158 US: LIVE CELL IMAGING MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION)
TABLE 159 US: LIVE CELL IMAGING INSTRUMENTS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 160 US: LIVE CELL IMAGING CONSUMABLES MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 161 US: LIVE CELL IMAGING MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
TABLE 162 US: LIVE CELL IMAGING MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION)
TABLE 163 US: LIVE CELL IMAGING MARKET, BY END USER, 2021–2028 (USD MILLION)
10.2.2 CANADA
10.2.2.1 Government initiatives to promote research to support market growth
TABLE 164 CANADA: LIVE CELL IMAGING MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION)
TABLE 165 CANADA: LIVE CELL IMAGING INSTRUMENTS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 166 CANADA: LIVE CELL IMAGING CONSUMABLES MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 167 CANADA: LIVE CELL IMAGING MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
TABLE 168 CANADA: LIVE CELL IMAGING MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION)
TABLE 169 CANADA: LIVE CELL IMAGING MARKET, BY END USER, 2021–2028 (USD MILLION)
10.2.3 NORTH AMERICA: RECESSION IMPACT
10.3 EUROPE
TABLE 170 EUROPE: LIVE CELL IMAGING MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 171 EUROPE: LIVE CELL IMAGING MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION)
TABLE 172 EUROPE: LIVE CELL IMAGING INSTRUMENTS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 173 EUROPE: LIVE CELL IMAGING CONSUMABLES MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 174 EUROPE: LIVE CELL IMAGING MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
TABLE 175 EUROPE: LIVE CELL IMAGING MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION)
TABLE 176 EUROPE: LIVE CELL IMAGING MARKET, BY END USER, 2021–2028 (USD MILLION)
10.3.1 GERMANY
10.3.1.1 Presence of large number of academic research institutes to boost market
TABLE 177 GERMANY: LIVE CELL IMAGING MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION)
TABLE 178 GERMANY: LIVE CELL IMAGING INSTRUMENTS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 179 GERMANY: LIVE CELL IMAGING CONSUMABLES MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 180 GERMANY: LIVE CELL IMAGING MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
TABLE 181 GERMANY: LIVE CELL IMAGING MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION)
TABLE 182 GERMANY: LIVE CELL IMAGING MARKET, BY END USER, 2021–2028 (USD MILLION)
10.3.2 UK
10.3.2.1 Investments by pharmaceutical sponsors for drug discovery services to support market
FIGURE 31 UK: PHARMACEUTICAL R&D EXPENDITURE, 2011–2020 (USD MILLION)
TABLE 183 UK: LIVE CELL IMAGING MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION)
TABLE 184 UK: LIVE CELL IMAGING INSTRUMENTS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 185 UK: LIVE CELL IMAGING CONSUMABLES MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 186 UK: LIVE CELL IMAGING MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
TABLE 187 UK: LIVE CELL IMAGING MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION)
TABLE 188 UK: LIVE CELL IMAGING MARKET, BY END USER, 2021–2028 (USD MILLION)
10.3.3 FRANCE
10.3.3.1 Large pharmaceutical manufacturing industry to drive market growth
TABLE 189 FRANCE: LIVE CELL IMAGING MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION)
TABLE 190 FRANCE: LIVE CELL IMAGING INSTRUMENTS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 191 FRANCE: LIVE CELL IMAGING CONSUMABLES MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 192 FRANCE: LIVE CELL IMAGING MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
TABLE 193 FRANCE: LIVE CELL IMAGING MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION)
TABLE 194 FRANCE: LIVE CELL IMAGING MARKET, BY END USER, 2021–2028 (USD MILLION)
10.3.4 ITALY
10.3.4.1 Strong research tradition, government funding, and collaborative research networks to fuel growth
TABLE 195 ITALY: LIVE CELL IMAGING MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION)
TABLE 196 ITALY: LIVE CELL IMAGING INSTRUMENTS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 197 ITALY: LIVE CELL IMAGING CONSUMABLES MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 198 ITALY: LIVE CELL IMAGING MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
TABLE 199 ITALY: LIVE CELL IMAGING MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION)
TABLE 200 ITALY: LIVE CELL IMAGING MARKET, BY END USER, 2021–2028 (USD MILLION)
10.3.5 SPAIN
10.3.5.1 Rising R&D expenditure to boost market
TABLE 201 SPAIN: LIVE CELL IMAGING MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION)
TABLE 202 SPAIN: LIVE CELL IMAGING INSTRUMENTS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 203 SPAIN: LIVE CELL IMAGING CONSUMABLES MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 204 SPAIN: LIVE CELL IMAGING MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
TABLE 205 SPAIN: LIVE CELL IMAGING MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION)
TABLE 206 SPAIN: LIVE CELL IMAGING MARKET, BY END USER, 2021–2028 (USD MILLION)
10.3.6 REST OF EUROPE
TABLE 207 REST OF EUROPE: LIVE CELL IMAGING MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION)
TABLE 208 REST OF EUROPE: LIVE CELL IMAGING INSTRUMENTS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 209 REST OF EUROPE: LIVE CELL IMAGING CONSUMABLES MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 210 REST OF EUROPE: LIVE CELL IMAGING MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
TABLE 211 REST OF EUROPE: LIVE CELL IMAGING MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION)
TABLE 212 REST OF EUROPE: LIVE CELL IMAGING MARKET, BY END USER, 2021–2028 (USD MILLION)
10.3.7 EUROPE: RECESSION IMPACT
10.4 ASIA PACIFIC
TABLE 213 ASIA PACIFIC: LIVE CELL IMAGING MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 214 ASIA PACIFIC: LIVE CELL IMAGING MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION)
TABLE 215 ASIA PACIFIC: LIVE CELL IMAGING INSTRUMENTS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 216 ASIA PACIFIC: LIVE CELL IMAGING CONSUMABLES MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 217 ASIA PACIFIC: LIVE CELL IMAGING MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
TABLE 218 ASIA PACIFIC: LIVE CELL IMAGING MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION)
TABLE 219 ASIA PACIFIC: LIVE CELL IMAGING MARKET, BY END USER, 2021–2028 (USD MILLION)
10.4.1 CHINA
10.4.1.1 China to dominate APAC live cell imaging market
TABLE 220 CHINA: LIVE CELL IMAGING MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION)
TABLE 221 CHINA: LIVE CELL IMAGING INSTRUMENTS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 222 CHINA: LIVE CELL IMAGING CONSUMABLES MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 223 CHINA: LIVE CELL IMAGING MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
TABLE 224 CHINA: LIVE CELL IMAGING MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION)
TABLE 225 CHINA: LIVE CELL IMAGING MARKET, BY END USER, 2021–2028 (USD MILLION)
10.4.2 JAPAN
10.4.2.1 Rising prominence of regenerative medicine research to drive market growth
TABLE 226 JAPAN: LIVE CELL IMAGING MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION)
TABLE 227 JAPAN: LIVE CELL IMAGING INSTRUMENTS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 228 JAPAN: LIVE CELL IMAGING CONSUMABLES MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 229 JAPAN: LIVE CELL IMAGING MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
TABLE 230 JAPAN: LIVE CELL IMAGING MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION)
TABLE 231 JAPAN: LIVE CELL IMAGING MARKET, BY END USER, 2021–2028 (USD MILLION)
10.4.3 INDIA
10.4.3.1 Growing pharmaceutical industry to create favorable opportunities for market players
TABLE 232 INDIA: LIVE CELL IMAGING MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION)
TABLE 233 INDIA: LIVE CELL IMAGING INSTRUMENTS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 234 INDIA: LIVE CELL IMAGING CONSUMABLES MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 235 INDIA: LIVE CELL IMAGING MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
TABLE 236 INDIA: LIVE CELL IMAGING MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION)
TABLE 237 INDIA: LIVE CELL IMAGING MARKET, BY END USER, 2021–2028 (USD MILLION)
10.4.4 REST OF ASIA PACIFIC (ROAPAC)
TABLE 238 REST OF ASIA PACIFIC: LIVE CELL IMAGING MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION)
TABLE 239 REST OF ASIA PACIFIC: LIVE CELL IMAGING INSTRUMENTS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 240 REST OF ASIA PACIFIC: LIVE CELL IMAGING CONSUMABLES MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 241 REST OF ASIA PACIFIC: LIVE CELL IMAGING MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
TABLE 242 REST OF ASIA PACIFIC: LIVE CELL IMAGING MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION)
TABLE 243 REST OF ASIA PACIFIC: LIVE CELL IMAGING MARKET, BY END USER, 2021–2028 (USD MILLION)
10.4.5 ASIA PACIFIC: RECESSION IMPACT
10.5 LATIN AMERICA
TABLE 244 LATIN AMERICA: LIVE CELL IMAGING MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 245 LATIN AMERICA: LIVE CELL IMAGING MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION)
TABLE 246 LATIN AMERICA: LIVE CELL IMAGING INSTRUMENTS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 247 LATIN AMERICA: LIVE CELL IMAGING CONSUMABLES MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 248 LATIN AMERICA: LIVE CELL IMAGING MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
TABLE 249 LATIN AMERICA: LIVE CELL IMAGING MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION)
TABLE 250 LATIN AMERICA: LIVE CELL IMAGING MARKET, BY END USER, 2021–2028 (USD MILLION)
10.5.1 BRAZIL
10.5.1.1 Gradual growth in research to contribute to growth
TABLE 251 BRAZIL: LIVE CELL IMAGING MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION)
TABLE 252 BRAZIL: LIVE CELL IMAGING INSTRUMENTS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 253 BRAZIL: LIVE CELL IMAGING CONSUMABLES MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 254 BRAZIL: LIVE CELL IMAGING MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
TABLE 255 BRAZIL: LIVE CELL IMAGING MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION)
TABLE 256 BRAZIL: LIVE CELL IMAGING MARKET, BY END USER, 2021–2028 (USD MILLION)
10.5.2 REST OF LATIN AMERICA
TABLE 257 REST OF LATIN AMERICA: LIVE CELL IMAGING MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION)
TABLE 258 REST OF LATIN AMERICA: LIVE CELL IMAGING INSTRUMENTS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 259 REST OF LATIN AMERICA: LIVE CELL IMAGING CONSUMABLES MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 260 REST OF LATIN AMERICA: LIVE CELL IMAGING MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
TABLE 261 REST OF LATIN AMERICA: LIVE CELL IMAGING MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION)
TABLE 262 REST OF LATIN AMERICA: LIVE CELL IMAGING MARKET, BY END USER, 2021–2028 (USD MILLION)
10.5.3 LATIN AMERICA: RECESSION IMPACT
10.6 MIDDLE EAST & AFRICA
10.6.1 GROWING PHARMACEUTICAL INDUSTRY TO DRIVE MARKET GROWTH
TABLE 263 MIDDLE EAST & AFRICA: LIVE CELL IMAGING MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION)
TABLE 264 MIDDLE EAST & AFRICA: LIVE CELL IMAGING INSTRUMENTS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 265 MIDDLE EAST & AFRICA: LIVE CELL IMAGING CONSUMABLES MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 266 MIDDLE EAST & AFRICA: LIVE CELL IMAGING MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
TABLE 267 MIDDLE EAST & AFRICA: LIVE CELL IMAGING MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION)
TABLE 268 MIDDLE EAST & AFRICA: LIVE CELL IMAGING MARKET, BY END USER, 2021–2028 (USD MILLION)
10.6.2 MIDDLE EAST & AFRICA: RECESSION IMPACT
11 COMPETITIVE LANDSCAPE
11.1 INTRODUCTION
11.2 STRATEGIES ADOPTED BY KEY PLAYERS
FIGURE 32 LIVE CELL IMAGING MARKET: STRATEGIES ADOPTED BY KEY PLAYERS
11.3 REVENUE SHARE ANALYSIS
FIGURE 33 REVENUE ANALYSIS OF KEY PLAYERS, 2020–2022
11.4 MARKET SHARE ANALYSIS
FIGURE 34 MARKET SHARE ANALYSIS OF KEY PLAYERS, 2022
TABLE 269 LIVE CELL IMAGING MARKET: DEGREE OF COMPETITION
11.5 COMPANY EVALUATION QUADRANT: KEY PLAYERS
FIGURE 35 LIVE CELL IMAGING MARKET: COMPANY EVALUATION MATRIX FOR KEY PLAYERS, 2022
11.5.1 STARS
11.5.2 EMERGING LEADERS
11.5.3 PERVASIVE PLAYERS
11.5.4 PARTICIPANTS
11.6 COMPETITIVE BENCHMARKING OF TOP 25 PLAYERS
11.6.1 END-USER FOOTPRINT OF COMPANIES (25 COMPANIES)
TABLE 270 END-USER FOOTPRINT ANALYSIS OF KEY PLAYERS IN LIVE CELL IMAGING MARKET
11.6.2 PRODUCT & SERVICE FOOTPRINT OF COMPANIES (25 COMPANIES)
TABLE 271 PRODUCT & SERVICE FOOTPRINT ANALYSIS OF KEY PLAYERS IN LIVE CELL IMAGING MARKET
11.6.3 REGIONAL FOOTPRINT OF COMPANIES (25 COMPANIES)
TABLE 272 REGIONAL FOOTPRINT ANALYSIS OF KEY PLAYERS IN LIVE CELL IMAGING MARKET
11.7 COMPANY EVALUATION QUADRANT: START-UPS/SMES
FIGURE 36 LIVE CELL IMAGING MARKET: COMPANY EVALUATION MATRIX FOR START-UPS/SMES, 2022
11.7.1 PROGRESSIVE COMPANIES
11.7.2 STARTING BLOCKS
11.7.3 RESPONSIVE COMPANIES
11.7.4 DYNAMIC COMPANIES
11.8 COMPETITIVE BENCHMARKING OF START-UP/SME PLAYERS
TABLE 273 LIVE CELL IMAGING MARKET: DETAILED LIST OF KEY START-UP/SME PLAYERS
TABLE 274 LIVE CELL IMAGING MARKET: COMPETITIVE BENCHMARKING OF START-UP/SME PLAYERS
11.9 COMPETITIVE SCENARIO AND TRENDS
11.9.1 PRODUCT LAUNCHES
TABLE 275 LIVE CELL IMAGING MARKET: PRODUCT LAUNCHES, JANUARY 2020–DECEMBER 2022
11.9.2 DEALS
TABLE 276 LIVE CELL IMAGING MARKET: DEALS, JANUARY 2020–DECEMBER 2022
11.9.3 OTHER DEVELOPMENTS
TABLE 277 LIVE CELL IMAGING MARKET: OTHER DEVELOPMENTS, JANUARY 2020–DECEMBER 2022
12 COMPANY PROFILES
12.1 KEY COMPANIES
(Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats))*
12.1.1 DANAHER
TABLE 278 DANAHER: BUSINESS OVERVIEW
FIGURE 37 DANAHER: COMPANY SNAPSHOT (2022)
12.1.2 ZEISS GROUP
TABLE 279 ZEISS GROUP: BUSINESS OVERVIEW
FIGURE 38 ZEISS GROUP: COMPANY SNAPSHOT (2022)
12.1.3 SARTORIUS AG
TABLE 280 SARTORIUS AG: BUSINESS OVERVIEW
FIGURE 39 SARTORIUS AG: COMPANY SNAPSHOT (2022)
12.1.4 THERMO FISHER SCIENTIFIC, INC.
TABLE 281 THERMO FISHER SCIENTIFIC, INC.: BUSINESS OVERVIEW
FIGURE 40 THERMO FISHER SCIENTIFIC, INC.: COMPANY SNAPSHOT (2022)
12.1.5 OLYMPUS CORPORATION
TABLE 282 OLYMPUS CORPORATION: BUSINESS OVERVIEW
FIGURE 41 OLYMPUS CORPORATION: COMPANY SNAPSHOT (2022)
12.1.6 PERKINELMER INC.
TABLE 283 PERKINELMER INC.: BUSINESS OVERVIEW
FIGURE 42 PERKINELMER INC.: COMPANY SNAPSHOT (2023)
12.1.7 NIKON CORPORATION
TABLE 284 NIKON CORPORATION: BUSINESS OVERVIEW
FIGURE 43 NIKON CORPORATION: COMPANY SNAPSHOT (2022)
12.1.8 ETALUMA, INC.
TABLE 285 ETALUMA, INC.: BUSINESS OVERVIEW
12.1.9 CYTOSMART TECHNOLOGIES
TABLE 286 CYTOSMART TECHNOLOGIES.: BUSINESS OVERVIEW
12.1.10 AGILENT TECHNOLOGIES, INC.
TABLE 287 AGILENT TECHNOLOGIES, INC.: BUSINESS OVERVIEW
FIGURE 44 AGILENT TECHNOLOGIES, INC.: COMPANY SNAPSHOT (2022)
12.1.11 NANOENTEK INC.
12.1.12 BECTON, DICKINSON AND COMPANY
TABLE 288 BECTON, DICKINSON AND COMPANY: BUSINESS OVERVIEW
FIGURE 45 BECTON, DICKINSON AND COMPANY: COMPANY SNAPSHOT (2022)
12.1.13 GE HEALTHCARE
TABLE 289 GE HEALTHCARE: BUSINESS OVERVIEW
FIGURE 46 GE HEALTHCARE: COMPANY SNAPSHOT (2022)
12.1.14 BRUKER CORPORATION
TABLE 290 BRUKER CORPORATION: BUSINESS OVERVIEW
FIGURE 47 BRUKER CORPORATION: COMPANY SNAPSHOT (2022)
12.1.15 MERCK KGAA
TABLE 291 MERCK KGAA: BUSINESS OVERVIEW
FIGURE 48 MERCK KGAA: COMPANY SNAPSHOT (2022)
12.1.16 BIO-RAD LABORATORIES, INC.
TABLE 292 BIO-RAD LABORATORIES, INC.: BUSINESS OVERVIEW
FIGURE 49 BIO-RAD LABORATORIES, INC.: COMPANY SNAPSHOT (2022)
12.1.17 CORNING INCORPORATED
TABLE 293 CORNING INCORPORATED: BUSINESS OVERVIEW
FIGURE 50 CORNING INCORPORATED: COMPANY SNAPSHOT (2022)
12.2 OTHER PLAYERS
12.2.1 BLUE-RAY BIOTECH CORP.
12.2.2 CYTENA GMBH
12.2.3 NANOLIVE SA
12.2.4 ABBERIOR
12.2.5 PHASE HOLOGRAPHIC IMAGING PHI AB
12.2.6 CYTOSKELETON, INC.
12.2.7 KEYENCE CORPORATION
12.2.8 ALIGNED GENETICS, INC.
*Details on Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats) might not be captured in case of unlisted companies.
13 APPENDIX
13.1 DISCUSSION GUIDE
13.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
13.3 CUSTOMIZATION OPTIONS
13.4 RELATED REPORTS
13.5 AUTHOR DETAILS
1.1 STUDY OBJECTIVES
1.2 MARKET DEFINITION
1.2.1 INCLUSIONS & EXCLUSIONS
1.3 MARKET SCOPE
FIGURE 1 LIVE CELL IMAGING MARKET SEGMENTATION
1.3.1 YEARS CONSIDERED
1.4 CURRENCY
1.5 LIMITATIONS
1.6 STAKEHOLDERS
1.7 SUMMARY OF CHANGES
1.7.1 RECESSION IMPACT
2 RESEARCH METHODOLOGY
2.1 RESEARCH DATA
FIGURE 2 RESEARCH DESIGN
2.1.1 SECONDARY DATA
2.1.2 PRIMARY DATA
FIGURE 3 LIVE CELL IMAGING MARKET: BREAKDOWN OF PRIMARIES
2.2 MARKET SIZE ESTIMATION
FIGURE 4 MARKET SIZE ESTIMATION: SUPPLY-SIDE ANALYSIS, 2022
FIGURE 5 MARKET SIZE ESTIMATION: APPROACH 1 (REVENUE SHARE ANALYSIS), 2022
FIGURE 6 ILLUSTRATIVE EXAMPLE OF DANAHER CORPORATION: REVENUE SHARE ANALYSIS, 2022
2.2.1 INSIGHTS FROM PRIMARIES
FIGURE 7 MARKET VALIDATION FROM PRIMARY EXPERTS
FIGURE 8 MARKET SIZE ESTIMATION METHODOLOGY: TOP-DOWN APPROACH
2.3 GROWTH FORECAST
FIGURE 9 LIVE CELL IMAGING MARKET: CAGR PROJECTIONS, 2022–2028
FIGURE 10 LIVE CELL IMAGING MARKET: GROWTH ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
2.4 MARKET BREAKDOWN AND DATA TRIANGULATION
FIGURE 11 DATA TRIANGULATION METHODOLOGY
2.5 RESEARCH ASSUMPTIONS
2.6 RISK ANALYSIS
2.7 RECESSION IMPACT ON LIVE CELL IMAGING MARKET
TABLE 1 GLOBAL INFLATION RATE PROJECTIONS, 2021–2027 (% GROWTH)
TABLE 2 US HEALTH EXPENDITURE, 2019–2022 (USD MILLION)
TABLE 3 US HEALTH EXPENDITURE, 2023–2027 (USD MILLION)
3 EXECUTIVE SUMMARY
FIGURE 12 LIVE CELL IMAGING MARKET, BY PRODUCT & SERVICE, 2023 VS. 2028 (USD MILLION)
FIGURE 13 LIVE CELL IMAGING MARKET, BY APPLICATION, 2023 VS. 2028 (USD MILLION)
FIGURE 14 LIVE CELL IMAGING MARKET, BY TECHNOLOGY, 2023 VS. 2028 (USD MILLION)
FIGURE 15 LIVE CELL IMAGING MARKET, BY END USER, 2023 VS. 2028 (USD MILLION)
FIGURE 16 GEOGRAPHICAL SNAPSHOT OF LIVE CELL IMAGING MARKET
4 PREMIUM INSIGHTS
4.1 LIVE CELL IMAGING MARKET OVERVIEW
FIGURE 17 GROWING ADOPTION OF HIGH-CONTENT SCREENING TECHNIQUES IN DRUG DISCOVERY TO DRIVE MARKET GROWTH
4.2 NORTH AMERICA: LIVE CELL IMAGING MARKET SHARE, BY PRODUCT & SERVICE AND COUNTRY (2022)
FIGURE 18 INSTRUMENTS DOMINATED NORTH AMERICAN LIVE CELL IMAGING MARKET IN 2022
4.3 LIVE CELL IMAGING MARKET, BY PRODUCT & SERVICE, 2023 VS. 2028 (USD MILLION)
FIGURE 19 INSTRUMENTS TO CONTINUE TO DOMINATE MARKET BY 2028
4.4 LIVE CELL IMAGING MARKET SHARE, BY END USER, 2022
FIGURE 20 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES ACCOUNTED FOR LARGEST MARKET SHARE IN 2022
4.5 LIVE CELL IMAGING MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES
FIGURE 21 ASIA PACIFIC TO REGISTER HIGHEST GROWTH RATE IN LIVE CELL IMAGING MARKET FROM 2023 TO 2028
5 MARKET OVERVIEW
5.1 INTRODUCTION
5.2 MARKET DYNAMICS
FIGURE 22 LIVE CELL IMAGING MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
TABLE 4 LIVE CELL IMAGING MARKET: IMPACT ANALYSIS
5.2.1 DRIVERS
5.2.1.1 Growing adoption of high-content screening techniques in drug discovery
5.2.1.2 Rising incidence of cancer
TABLE 5 ESTIMATED NEW CANCER CASES IN US, 2023
FIGURE 23 GLOBAL CANCER INCIDENCE & MORTALITY, 2020
5.2.1.3 Growing availability of research funds
TABLE 6 INVESTMENT BREAKDOWN, 2021 (USD MILLION)
5.2.2 RESTRAINTS
5.2.2.1 High cost of high-content screening systems
5.2.3 OPPORTUNITIES
5.2.3.1 Increasing adoption of live cell imaging technologies in emerging economies
5.2.3.2 Applications of HCS in personalized medicine
5.2.4 CHALLENGES
5.2.4.1 Maintaining cell viability and cellular environment in cell cultures
5.2.4.2 Image analysis and data management
5.3 TECHNOLOGY ANALYSIS
5.4 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES
FIGURE 24 REVENUE SHIFT & NEW POCKETS FOR LIVE CELL IMAGING PRODUCT & SERVICE PROVIDERS
5.5 VALUE/SUPPLY CHAIN ANALYSIS
5.5.1 VALUE CHAIN ANALYSIS
FIGURE 25 LIVE CELL IMAGING MARKET: VALUE CHAIN ANALYSIS
5.5.2 SUPPLY CHAIN ANALYSIS
FIGURE 26 LIVE CELL IMAGING MARKET: SUPPLY CHAIN ANALYSIS
5.6 REGULATORY ANALYSIS
5.6.1 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
5.6.1.1 North America
5.6.1.1.1 US
5.6.1.1.2 Canada
5.6.1.2 Europe
5.6.1.3 Asia Pacific
5.6.1.4 Rest of the World
5.7 PORTER’S FIVE FORCES ANALYSIS
TABLE 7 LIVE CELL IMAGING MARKET: PORTER’S FIVE FORCES ANALYSIS
5.7.1 THREAT OF NEW ENTRANTS
5.7.2 THREAT OF SUBSTITUTES
5.7.3 BARGAINING POWER OF SUPPLIERS
5.7.4 BARGAINING POWER OF BUYERS
5.7.5 INTENSITY OF COMPETITIVE RIVALRY
5.8 ECOSYSTEM ANALYSIS
TABLE 8 SUPPLY CHAIN ECOSYSTEM
5.9 PRICING ANALYSIS
5.9.1 AVERAGE SELLING PRICE, BY KEY PLAYER
TABLE 9 AVERAGE SELLING PRICES
5.9.2 AVERAGE SELLING PRICE TREND
5.10 KEY CONFERENCES & EVENTS IN 2022–2023
TABLE 10 LIVE CELL IMAGING: DETAILED LIST OF CONFERENCES & EVENTS
5.11 KEY STAKEHOLDERS AND BUYING CRITERIA
5.11.1 KEY STAKEHOLDERS IN BUYING PROCESS
FIGURE 27 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS OF LIVE CELL IMAGING PRODUCTS
5.11.2 BUYING CRITERIA FOR LIVE CELL IMAGING
FIGURE 28 KEY BUYING CRITERIA FOR END USERS
5.12 PATENT ANALYSIS
FIGURE 29 LIVE CELL IMAGING MARKET: PATENT APPLICATIONS (JANUARY 2020–APRIL 2023)
6 LIVE CELL IMAGING MARKET, BY PRODUCT & SERVICE
6.1 INTRODUCTION
TABLE 11 LIVE CELL IMAGING MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION)
6.2 INSTRUMENTS
TABLE 12 EXAMPLES OF INSTRUMENTS OFFERED BY MARKET PLAYERS
TABLE 13 LIVE CELL IMAGING INSTRUMENTS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 14 LIVE CELL IMAGING INSTRUMENTS MARKET, BY REGION, 2021–2028 (USD MILLION)
TABLE 15 NORTH AMERICA: LIVE CELL IMAGING INSTRUMENTS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 16 EUROPE: LIVE CELL IMAGING INSTRUMENTS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 17 ASIA PACIFIC: LIVE CELL IMAGING INSTRUMENTS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 18 LATIN AMERICA: LIVE CELL IMAGING INSTRUMENTS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
6.2.1 MICROSCOPES
6.2.1.1 Continuous technological advancements in microscopes to support market
TABLE 19 CONVENTIONAL MICROSCOPES OFFERED BY KEY MARKET PLAYERS
TABLE 20 CONFOCAL MICROSCOPES OFFERED BY KEY MARKET PLAYERS
TABLE 21 FLUORESCENCE MICROSCOPES OFFERED BY KEY MARKET PLAYERS
TABLE 22 LIVE CELL IMAGING INSTRUMENTS MARKET FOR MICROSCOPES, BY REGION, 2021–2028 (USD MILLION)
TABLE 23 NORTH AMERICA: LIVE CELL IMAGING INSTRUMENTS MARKET FOR MICROSCOPES, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 24 EUROPE: LIVE CELL IMAGING INSTRUMENTS MARKET FOR MICROSCOPES, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 25 ASIA PACIFIC: LIVE CELL IMAGING INSTRUMENTS MARKET FOR MICROSCOPES, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 26 LATIN AMERICA: LIVE CELL IMAGING INSTRUMENTS MARKET FOR MICROSCOPES, BY COUNTRY, 2021–2028 (USD MILLION)
6.2.2 STANDALONE SYSTEMS
6.2.2.1 Seamless integration and workflow efficiency of standalone systems to boost demand
TABLE 27 STANDALONE SYSTEMS OFFERED BY KEY MARKET PLAYERS
TABLE 28 LIVE CELL IMAGING INSTRUMENTS MARKET FOR STANDALONE SYSTEMS, BY REGION, 2021–2028 (USD MILLION)
TABLE 29 NORTH AMERICA: LIVE CELL IMAGING INSTRUMENTS MARKET FOR STANDALONE SYSTEMS, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 30 EUROPE: LIVE CELL IMAGING INSTRUMENTS MARKET FOR STANDALONE SYSTEMS, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 31 ASIA PACIFIC: LIVE CELL IMAGING INSTRUMENTS MARKET FOR STANDALONE SYSTEMS, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 32 LATIN AMERICA: LIVE CELL IMAGING INSTRUMENTS MARKET FOR STANDALONE SYSTEMS, BY COUNTRY, 2021–2028 (USD MILLION)
6.2.3 CELL ANALYZERS
6.2.3.1 Accuracy and reproducibility of cell analyzers to support growth
TABLE 33 CELL ANALYZERS OFFERED BY KEY MARKET PLAYERS
TABLE 34 LIVE CELL IMAGING INSTRUMENTS MARKET FOR CELL ANALYZERS, BY REGION, 2021–2028 (USD MILLION)
TABLE 35 NORTH AMERICA: LIVE CELL IMAGING INSTRUMENTS MARKET FOR CELL ANALYZERS, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 36 EUROPE: LIVE CELL IMAGING INSTRUMENTS MARKET FOR CELL ANALYZERS, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 37 ASIA PACIFIC: LIVE CELL IMAGING INSTRUMENTS MARKET FOR CELL ANALYZERS, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 38 LATIN AMERICA: LIVE CELL IMAGING INSTRUMENTS MARKET FOR CELL ANALYZERS, BY COUNTRY, 2021–2028 (USD MILLION)
6.2.4 ACCESSORIES
6.2.4.1 Ability of accessories to optimize and enhance imaging conditions to boost demand
TABLE 39 ACCESSORIES OFFERED BY KEY MARKET PLAYERS
TABLE 40 LIVE CELL IMAGING INSTRUMENTS MARKET FOR ACCESSORIES, BY REGION, 2021–2028 (USD MILLION)
TABLE 41 NORTH AMERICA: LIVE CELL IMAGING INSTRUMENTS MARKET FOR ACCESSORIES, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 42 EUROPE: LIVE CELL IMAGING INSTRUMENTS MARKET FOR ACCESSORIES, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 43 ASIA PACIFIC: LIVE CELL IMAGING INSTRUMENTS MARKET FOR ACCESSORIES, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 44 LATIN AMERICA: LIVE CELL IMAGING INSTRUMENTS MARKET FOR ACCESSORIES, BY COUNTRY, 2021–2028 (USD MILLION)
6.3 CONSUMABLES
TABLE 45 LIVE CELL IMAGING CONSUMABLES MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 46 LIVE CELL IMAGING CONSUMABLES MARKET, BY REGION, 2021–2028 (USD MILLION)
TABLE 47 NORTH AMERICA: LIVE CELL IMAGING CONSUMABLES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 48 EUROPE: LIVE CELL IMAGING CONSUMABLES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 49 ASIA PACIFIC: LIVE CELL IMAGING CONSUMABLES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 50 LATIN AMERICA: LIVE CELL IMAGING CONSUMABLES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
6.3.1 REAGENTS
6.3.1.1 Widespread usage in life science research to fuel market growth
TABLE 51 REAGENTS OFFERED BY KEY MARKET PLAYERS
TABLE 52 LIVE CELL IMAGING CONSUMABLES MARKET FOR REAGENTS, BY REGION, 2021–2028 (USD MILLION)
TABLE 53 NORTH AMERICA: LIVE CELL IMAGING CONSUMABLES MARKET FOR REAGENTS, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 54 EUROPE: LIVE CELL IMAGING CONSUMABLES MARKET FOR REAGENTS, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 55 ASIA PACIFIC: LIVE CELL IMAGING CONSUMABLES MARKET FOR REAGENTS, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 56 LATIN AMERICA: LIVE CELL IMAGING CONSUMABLES MARKET FOR REAGENTS, BY COUNTRY, 2021–2028 (USD MILLION)
6.3.2 ASSAY KITS
6.3.2.1 Repeat purchase of assay kits to drive market
TABLE 57 ASSAY KITS OFFERED BY KEY MARKET PLAYERS
TABLE 58 LIVE CELL IMAGING CONSUMABLES MARKET FOR ASSAY KITS, BY REGION, 2021–2028 (USD MILLION)
TABLE 59 NORTH AMERICA: LIVE CELL IMAGING CONSUMABLES MARKET FOR ASSAY KITS, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 60 EUROPE: LIVE CELL IMAGING CONSUMABLES MARKET FOR ASSAY KITS, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 61 ASIA PACIFIC: LIVE CELL IMAGING CONSUMABLES MARKET FOR ASSAY KITS, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 62 LATIN AMERICA: LIVE CELL IMAGING CONSUMABLES MARKET FOR ASSAY KITS, BY COUNTRY, 2021–2028 (USD MILLION)
6.3.3 MEDIA
6.3.3.1 Increasing demand for optimized cell culture conditions to drive demand for media
TABLE 63 MEDIA OFFERED BY KEY MARKET PLAYERS
TABLE 64 LIVE CELL IMAGING CONSUMABLES MARKET FOR MEDIA, BY REGION, 2021–2028 (USD MILLION)
TABLE 65 NORTH AMERICA: LIVE CELL IMAGING CONSUMABLES MARKET FOR MEDIA, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 66 EUROPE: LIVE CELL IMAGING CONSUMABLES MARKET FOR MEDIA, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 67 ASIA PACIFIC: LIVE CELL IMAGING CONSUMABLES MARKET FOR MEDIA, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 68 LATIN AMERICA: LIVE CELL IMAGING CONSUMABLES MARKET FOR MEDIA, BY COUNTRY, 2021–2028 (USD MILLION)
6.3.4 OTHER CONSUMABLES
TABLE 69 OTHER CONSUMABLES OFFERED BY KEY MARKET PLAYERS
TABLE 70 OTHER LIVE CELL IMAGING CONSUMABLES MARKET, BY REGION, 2021–2028 (USD MILLION)
TABLE 71 NORTH AMERICA: OTHER LIVE CELL IMAGING CONSUMABLES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 72 EUROPE: OTHER LIVE CELL IMAGING CONSUMABLES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 73 ASIA PACIFIC: OTHER LIVE CELL IMAGING CONSUMABLES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 74 LATIN AMERICA: OTHER LIVE CELL IMAGING CONSUMABLES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
6.4 SOFTWARE
6.4.1 TECHNOLOGICAL ADVANCEMENTS IN IMAGE ACQUISITION TO BOOST MARKET GROWTH
TABLE 75 SOFTWARE OFFERED BY KEY MARKET PLAYERS
TABLE 76 LIVE CELL IMAGING SOFTWARE MARKET, BY REGION, 2021–2028 (USD MILLION)
TABLE 77 NORTH AMERICA: LIVE CELL IMAGING SOFTWARE MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 78 EUROPE: LIVE CELL IMAGING SOFTWARE MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 79 ASIA PACIFIC: LIVE CELL IMAGING SOFTWARE MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 80 LATIN AMERICA: LIVE CELL IMAGING SOFTWARE MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
6.5 SERVICES
6.5.1 GROWING DEMAND FOR OUTSOURCED EXPERTISE AND SPECIALIZED SERVICES TO SUPPORT MARKET
TABLE 81 LIVE CELL IMAGING SERVICES MARKET, BY REGION, 2021–2028 (USD MILLION)
TABLE 82 NORTH AMERICA: LIVE CELL IMAGING SERVICES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 83 EUROPE: LIVE CELL IMAGING SERVICES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 84 ASIA PACIFIC: LIVE CELL IMAGING SERVICES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 85 LATIN AMERICA: LIVE CELL IMAGING SERVICES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
7 LIVE CELL IMAGING MARKET, BY APPLICATION
7.1 INTRODUCTION
TABLE 86 LIVE CELL IMAGING MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
7.2 CELL BIOLOGY
TABLE 87 NUMBER OF NEW CANCER CASES, BY TYPE, 2020 VS. 2040
TABLE 88 LIVE CELL IMAGING MARKET FOR CELL BIOLOGY APPLICATIONS, BY REGION, 2021–2028 (USD MILLION)
TABLE 89 NORTH AMERICA: LIVE CELL IMAGING MARKET FOR CELL BIOLOGY APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 90 EUROPE: LIVE CELL IMAGING MARKET FOR CELL BIOLOGY APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 91 ASIA PACIFIC: LIVE CELL IMAGING MARKET FOR CELL BIOLOGY APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 92 LATIN AMERICA: LIVE CELL IMAGING MARKET FOR CELL BIOLOGY APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION)
7.3 STEM CELLS
7.3.1 GROWING FOCUS ON REGENERATIVE MEDICINE & ADVANCEMENTS IN STEM CELL RESEARCH TO BOOST MARKET
TABLE 93 LIVE CELL IMAGING MARKET FOR STEM CELL APPLICATIONS, BY REGION, 2021–2028 (USD MILLION)
TABLE 94 NORTH AMERICA: LIVE CELL IMAGING MARKET FOR STEM CELL APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 95 EUROPE: LIVE CELL IMAGING MARKET FOR STEM CELL APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 96 ASIA PACIFIC: LIVE CELL IMAGING MARKET FOR STEM CELL APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 97 LATIN AMERICA: LIVE CELL IMAGING MARKET FOR STEM CELL APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION)
7.4 DEVELOPMENTAL BIOLOGY
7.4.1 GROWING INTEREST IN UNDERSTANDING ORGANOGENESIS AND TISSUE MORPHOGENESIS TO DRIVE DEMAND
TABLE 98 LIVE CELL IMAGING MARKET FOR DEVELOPMENTAL BIOLOGY APPLICATIONS, BY REGION, 2021–2028 (USD MILLION)
TABLE 99 NORTH AMERICA: LIVE CELL IMAGING MARKET FOR DEVELOPMENTAL BIOLOGY APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 100 EUROPE: LIVE CELL IMAGING MARKET FOR DEVELOPMENTAL BIOLOGY APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 101 ASIA PACIFIC: LIVE CELL IMAGING MARKET FOR DEVELOPMENTAL BIOLOGY APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 102 LATIN AMERICA: LIVE CELL IMAGING MARKET FOR DEVELOPMENTAL BIOLOGY APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION)
7.5 DRUG DISCOVERY
7.5.1 GROWING USE OF HCS CELL-BASED ASSAYS IN DRUG DISCOVERY STUDIES TO DRIVE DEMAND
TABLE 103 LIVE CELL IMAGING MARKET FOR DRUG DISCOVERY APPLICATIONS, BY REGION, 2021–2028 (USD MILLION)
TABLE 104 NORTH AMERICA: LIVE CELL IMAGING MARKET FOR DRUG DISCOVERY APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 105 EUROPE: LIVE CELL IMAGING MARKET FOR DRUG DISCOVERY APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 106 ASIA PACIFIC: LIVE CELL IMAGING MARKET FOR DRUG DISCOVERY APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 107 LATIN AMERICA: LIVE CELL IMAGING MARKET FOR DRUG DISCOVERY APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION)
8 LIVE CELL IMAGING MARKET, BY TECHNOLOGY
8.1 INTRODUCTION
TABLE 108 LIVE CELL IMAGING MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION)
8.2 TIME-LAPSE MICROSCOPY
TABLE 109 LIVE CELL IMAGING MARKET FOR TIME-LAPSE MICROSCOPY, BY REGION, 2021–2028 (USD MILLION)
TABLE 110 NORTH AMERICA: LIVE CELL IMAGING MARKET FOR TIME-LAPSE MICROSCOPY, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 111 EUROPE: LIVE CELL IMAGING MARKET FOR TIME-LAPSE MICROSCOPY, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 112 ASIA PACIFIC: LIVE CELL IMAGING MARKET FOR TIME-LAPSE MICROSCOPY, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 113 LATIN AMERICA: LIVE CELL IMAGING MARKET FOR TIME-LAPSE MICROSCOPY, BY COUNTRY, 2021–2028 (USD MILLION)
8.3 FLUORESCENCE RESONANCE ENERGY TRANSFER (FRET)
8.3.1 ADVANCEMENTS IN FLUORESCENT MATERIALS AND PROBES TO BOOST ADOPTION OF FRET TECHNOLOGY
TABLE 114 LIVE CELL IMAGING MARKET FOR FLUORESCENCE RESONANCE ENERGY TRANSFER, BY REGION, 2021–2028 (USD MILLION)
TABLE 115 NORTH AMERICA: LIVE CELL IMAGING MARKET FOR FLUORESCENCE RESONANCE ENERGY TRANSFER, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 116 EUROPE: LIVE CELL IMAGING MARKET FOR FLUORESCENCE RESONANCE ENERGY TRANSFER, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 117 ASIA PACIFIC: LIVE CELL IMAGING MARKET FOR FLUORESCENCE RESONANCE ENERGY TRANSFER, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 118 LATIN AMERICA: LIVE CELL IMAGING MARKET FOR FLUORESCENCE RESONANCE ENERGY TRANSFER, BY COUNTRY, 2021–2028 (USD MILLION)
8.4 FLUORESCENCE RECOVERY AFTER PHOTOBLEACHING (FRAP)
8.4.1 INTEGRATION OF FRAP WITH LIVE CELL IMAGING MICROSCOPY TO CONTRIBUTE TO MARKET GROWTH
TABLE 119 LIVE CELL IMAGING MARKET FOR FLUORESCENCE RECOVERY AFTER PHOTOBLEACHING, BY REGION, 2021–2028 (USD MILLION)
TABLE 120 NORTH AMERICA: LIVE CELL IMAGING MARKET FOR FLUORESCENCE RECOVERY AFTER PHOTOBLEACHING, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 121 EUROPE: LIVE CELL IMAGING MARKET FOR FLUORESCENCE RECOVERY AFTER PHOTOBLEACHING, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 122 ASIA PACIFIC: LIVE CELL IMAGING MARKET FOR FLUORESCENCE RECOVERY AFTER PHOTOBLEACHING, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 123 LATIN AMERICA: LIVE CELL IMAGING MARKET FOR FLUORESCENCE RECOVERY AFTER PHOTOBLEACHING, BY COUNTRY, 2021–2028 (USD MILLION)
8.5 HIGH-CONTENT SCREENING (HCS)
8.5.1 GROWING ADOPTION OF HCS IN DRUG DISCOVERY AND TOXICITY SCREENING TO DRIVE GROWTH
TABLE 124 LIVE CELL IMAGING MARKET FOR HIGH-CONTENT SCREENING, BY REGION, 2021–2028 (USD MILLION)
TABLE 125 NORTH AMERICA: LIVE CELL IMAGING MARKET FOR HIGH-CONTENT SCREENING, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 126 EUROPE: LIVE CELL IMAGING MARKET FOR HIGH-CONTENT SCREENING, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 127 ASIA PACIFIC: LIVE CELL IMAGING MARKET FOR HIGH-CONTENT SCREENING, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 128 LATIN AMERICA: LIVE CELL IMAGING MARKET FOR HIGH-CONTENT SCREENING, BY COUNTRY, 2021–2028 (USD MILLION)
8.6 OTHER TECHNOLOGIES
TABLE 129 LIVE CELL IMAGING MARKET FOR OTHER TECHNOLOGIES, BY REGION, 2021–2028 (USD MILLION)
TABLE 130 NORTH AMERICA: LIVE CELL IMAGING MARKET FOR OTHER TECHNOLOGIES, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 131 EUROPE: LIVE CELL IMAGING MARKET FOR OTHER TECHNOLOGIES, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 132 ASIA PACIFIC: LIVE CELL IMAGING MARKET FOR OTHER TECHNOLOGIES, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 133 LATIN AMERICA: LIVE CELL IMAGING MARKET FOR OTHER TECHNOLOGIES, BY COUNTRY, 2021–2028 (USD MILLION)
9 LIVE CELL IMAGING MARKET, BY END USER
9.1 INTRODUCTION
TABLE 134 LIVE CELL IMAGING MARKET, BY END USER, 2021–2028 (USD MILLION)
9.2 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES
9.2.1 NEED TO ADHERE TO STRICT REGULATIONS TO DRIVE USE OF LIVE CELL IMAGING PRODUCTS AMONG PHARMA COMPANIES
TABLE 135 LIVE CELL IMAGING MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2021–2028 (USD MILLION)
TABLE 136 NORTH AMERICA: LIVE CELL IMAGING MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 137 EUROPE: LIVE CELL IMAGING MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 138 ASIA PACIFIC: LIVE CELL IMAGING MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 139 LATIN AMERICA: LIVE CELL IMAGING MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2021–2028 (USD MILLION)
9.3 ACADEMIC & RESEARCH INSTITUTES
9.3.1 INCREASING NUMBER OF DRUG DISCOVERY RESEARCH PROGRAMS TO DRIVE MARKET GROWTH
TABLE 140 LIVE CELL IMAGING MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2021–2028 (USD MILLION)
TABLE 141 NORTH AMERICA: LIVE CELL IMAGING MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 142 EUROPE: LIVE CELL IMAGING MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 143 ASIA PACIFIC: LIVE CELL IMAGING MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 144 LATIN AMERICA: LIVE CELL IMAGING MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2021–2028 (USD MILLION)
9.4 CONTRACT RESEARCH ORGANIZATIONS
9.4.1 GROWING OUTSOURCING OF R&D ACTIVITIES BY PHARMACEUTICAL COMPANIES TO DRIVE DEMAND
TABLE 145 LIVE CELL IMAGING MARKET FOR CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2021–2028 (USD MILLION)
TABLE 146 NORTH AMERICA: LIVE CELL IMAGING MARKET FOR CONTRACT RESEARCH ORGANIZATIONS, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 147 EUROPE: LIVE CELL IMAGING MARKET FOR F CONTRACT RESEARCH ORGANIZATIONS, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 148 ASIA PACIFIC: LIVE CELL IMAGING MARKET FOR CONTRACT RESEARCH ORGANIZATIONS, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 149 LATIN AMERICA: LIVE CELL IMAGING MARKET FOR CONTRACT RESEARCH ORGANIZATIONS, BY COUNTRY, 2021–2028 (USD MILLION)
10 LIVE CELL IMAGING MARKET, BY REGION
10.1 INTRODUCTION
TABLE 150 LIVE CELL IMAGING MARKET, BY REGION, 2021–2028 (USD MILLION)
10.2 NORTH AMERICA
FIGURE 30 NORTH AMERICA: LIVE CELL IMAGING MARKET SNAPSHOT
TABLE 151 NORTH AMERICA: LIVE CELL IMAGING MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 152 NORTH AMERICA: LIVE CELL IMAGING MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION)
TABLE 153 NORTH AMERICA: LIVE CELL IMAGING INSTRUMENTS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 154 NORTH AMERICA: LIVE CELL IMAGING CONSUMABLES MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 155 NORTH AMERICA: LIVE CELL IMAGING MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
TABLE 156 NORTH AMERICA: LIVE CELL IMAGING MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION)
TABLE 157 NORTH AMERICA: LIVE CELL IMAGING MARKET, BY END USER, 2021–2028 (USD MILLION)
10.2.1 US
10.2.1.1 US to dominate live cell imaging market in North America
TABLE 158 US: LIVE CELL IMAGING MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION)
TABLE 159 US: LIVE CELL IMAGING INSTRUMENTS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 160 US: LIVE CELL IMAGING CONSUMABLES MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 161 US: LIVE CELL IMAGING MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
TABLE 162 US: LIVE CELL IMAGING MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION)
TABLE 163 US: LIVE CELL IMAGING MARKET, BY END USER, 2021–2028 (USD MILLION)
10.2.2 CANADA
10.2.2.1 Government initiatives to promote research to support market growth
TABLE 164 CANADA: LIVE CELL IMAGING MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION)
TABLE 165 CANADA: LIVE CELL IMAGING INSTRUMENTS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 166 CANADA: LIVE CELL IMAGING CONSUMABLES MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 167 CANADA: LIVE CELL IMAGING MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
TABLE 168 CANADA: LIVE CELL IMAGING MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION)
TABLE 169 CANADA: LIVE CELL IMAGING MARKET, BY END USER, 2021–2028 (USD MILLION)
10.2.3 NORTH AMERICA: RECESSION IMPACT
10.3 EUROPE
TABLE 170 EUROPE: LIVE CELL IMAGING MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 171 EUROPE: LIVE CELL IMAGING MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION)
TABLE 172 EUROPE: LIVE CELL IMAGING INSTRUMENTS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 173 EUROPE: LIVE CELL IMAGING CONSUMABLES MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 174 EUROPE: LIVE CELL IMAGING MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
TABLE 175 EUROPE: LIVE CELL IMAGING MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION)
TABLE 176 EUROPE: LIVE CELL IMAGING MARKET, BY END USER, 2021–2028 (USD MILLION)
10.3.1 GERMANY
10.3.1.1 Presence of large number of academic research institutes to boost market
TABLE 177 GERMANY: LIVE CELL IMAGING MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION)
TABLE 178 GERMANY: LIVE CELL IMAGING INSTRUMENTS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 179 GERMANY: LIVE CELL IMAGING CONSUMABLES MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 180 GERMANY: LIVE CELL IMAGING MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
TABLE 181 GERMANY: LIVE CELL IMAGING MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION)
TABLE 182 GERMANY: LIVE CELL IMAGING MARKET, BY END USER, 2021–2028 (USD MILLION)
10.3.2 UK
10.3.2.1 Investments by pharmaceutical sponsors for drug discovery services to support market
FIGURE 31 UK: PHARMACEUTICAL R&D EXPENDITURE, 2011–2020 (USD MILLION)
TABLE 183 UK: LIVE CELL IMAGING MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION)
TABLE 184 UK: LIVE CELL IMAGING INSTRUMENTS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 185 UK: LIVE CELL IMAGING CONSUMABLES MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 186 UK: LIVE CELL IMAGING MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
TABLE 187 UK: LIVE CELL IMAGING MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION)
TABLE 188 UK: LIVE CELL IMAGING MARKET, BY END USER, 2021–2028 (USD MILLION)
10.3.3 FRANCE
10.3.3.1 Large pharmaceutical manufacturing industry to drive market growth
TABLE 189 FRANCE: LIVE CELL IMAGING MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION)
TABLE 190 FRANCE: LIVE CELL IMAGING INSTRUMENTS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 191 FRANCE: LIVE CELL IMAGING CONSUMABLES MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 192 FRANCE: LIVE CELL IMAGING MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
TABLE 193 FRANCE: LIVE CELL IMAGING MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION)
TABLE 194 FRANCE: LIVE CELL IMAGING MARKET, BY END USER, 2021–2028 (USD MILLION)
10.3.4 ITALY
10.3.4.1 Strong research tradition, government funding, and collaborative research networks to fuel growth
TABLE 195 ITALY: LIVE CELL IMAGING MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION)
TABLE 196 ITALY: LIVE CELL IMAGING INSTRUMENTS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 197 ITALY: LIVE CELL IMAGING CONSUMABLES MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 198 ITALY: LIVE CELL IMAGING MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
TABLE 199 ITALY: LIVE CELL IMAGING MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION)
TABLE 200 ITALY: LIVE CELL IMAGING MARKET, BY END USER, 2021–2028 (USD MILLION)
10.3.5 SPAIN
10.3.5.1 Rising R&D expenditure to boost market
TABLE 201 SPAIN: LIVE CELL IMAGING MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION)
TABLE 202 SPAIN: LIVE CELL IMAGING INSTRUMENTS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 203 SPAIN: LIVE CELL IMAGING CONSUMABLES MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 204 SPAIN: LIVE CELL IMAGING MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
TABLE 205 SPAIN: LIVE CELL IMAGING MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION)
TABLE 206 SPAIN: LIVE CELL IMAGING MARKET, BY END USER, 2021–2028 (USD MILLION)
10.3.6 REST OF EUROPE
TABLE 207 REST OF EUROPE: LIVE CELL IMAGING MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION)
TABLE 208 REST OF EUROPE: LIVE CELL IMAGING INSTRUMENTS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 209 REST OF EUROPE: LIVE CELL IMAGING CONSUMABLES MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 210 REST OF EUROPE: LIVE CELL IMAGING MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
TABLE 211 REST OF EUROPE: LIVE CELL IMAGING MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION)
TABLE 212 REST OF EUROPE: LIVE CELL IMAGING MARKET, BY END USER, 2021–2028 (USD MILLION)
10.3.7 EUROPE: RECESSION IMPACT
10.4 ASIA PACIFIC
TABLE 213 ASIA PACIFIC: LIVE CELL IMAGING MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 214 ASIA PACIFIC: LIVE CELL IMAGING MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION)
TABLE 215 ASIA PACIFIC: LIVE CELL IMAGING INSTRUMENTS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 216 ASIA PACIFIC: LIVE CELL IMAGING CONSUMABLES MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 217 ASIA PACIFIC: LIVE CELL IMAGING MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
TABLE 218 ASIA PACIFIC: LIVE CELL IMAGING MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION)
TABLE 219 ASIA PACIFIC: LIVE CELL IMAGING MARKET, BY END USER, 2021–2028 (USD MILLION)
10.4.1 CHINA
10.4.1.1 China to dominate APAC live cell imaging market
TABLE 220 CHINA: LIVE CELL IMAGING MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION)
TABLE 221 CHINA: LIVE CELL IMAGING INSTRUMENTS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 222 CHINA: LIVE CELL IMAGING CONSUMABLES MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 223 CHINA: LIVE CELL IMAGING MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
TABLE 224 CHINA: LIVE CELL IMAGING MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION)
TABLE 225 CHINA: LIVE CELL IMAGING MARKET, BY END USER, 2021–2028 (USD MILLION)
10.4.2 JAPAN
10.4.2.1 Rising prominence of regenerative medicine research to drive market growth
TABLE 226 JAPAN: LIVE CELL IMAGING MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION)
TABLE 227 JAPAN: LIVE CELL IMAGING INSTRUMENTS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 228 JAPAN: LIVE CELL IMAGING CONSUMABLES MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 229 JAPAN: LIVE CELL IMAGING MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
TABLE 230 JAPAN: LIVE CELL IMAGING MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION)
TABLE 231 JAPAN: LIVE CELL IMAGING MARKET, BY END USER, 2021–2028 (USD MILLION)
10.4.3 INDIA
10.4.3.1 Growing pharmaceutical industry to create favorable opportunities for market players
TABLE 232 INDIA: LIVE CELL IMAGING MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION)
TABLE 233 INDIA: LIVE CELL IMAGING INSTRUMENTS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 234 INDIA: LIVE CELL IMAGING CONSUMABLES MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 235 INDIA: LIVE CELL IMAGING MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
TABLE 236 INDIA: LIVE CELL IMAGING MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION)
TABLE 237 INDIA: LIVE CELL IMAGING MARKET, BY END USER, 2021–2028 (USD MILLION)
10.4.4 REST OF ASIA PACIFIC (ROAPAC)
TABLE 238 REST OF ASIA PACIFIC: LIVE CELL IMAGING MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION)
TABLE 239 REST OF ASIA PACIFIC: LIVE CELL IMAGING INSTRUMENTS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 240 REST OF ASIA PACIFIC: LIVE CELL IMAGING CONSUMABLES MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 241 REST OF ASIA PACIFIC: LIVE CELL IMAGING MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
TABLE 242 REST OF ASIA PACIFIC: LIVE CELL IMAGING MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION)
TABLE 243 REST OF ASIA PACIFIC: LIVE CELL IMAGING MARKET, BY END USER, 2021–2028 (USD MILLION)
10.4.5 ASIA PACIFIC: RECESSION IMPACT
10.5 LATIN AMERICA
TABLE 244 LATIN AMERICA: LIVE CELL IMAGING MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 245 LATIN AMERICA: LIVE CELL IMAGING MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION)
TABLE 246 LATIN AMERICA: LIVE CELL IMAGING INSTRUMENTS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 247 LATIN AMERICA: LIVE CELL IMAGING CONSUMABLES MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 248 LATIN AMERICA: LIVE CELL IMAGING MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
TABLE 249 LATIN AMERICA: LIVE CELL IMAGING MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION)
TABLE 250 LATIN AMERICA: LIVE CELL IMAGING MARKET, BY END USER, 2021–2028 (USD MILLION)
10.5.1 BRAZIL
10.5.1.1 Gradual growth in research to contribute to growth
TABLE 251 BRAZIL: LIVE CELL IMAGING MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION)
TABLE 252 BRAZIL: LIVE CELL IMAGING INSTRUMENTS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 253 BRAZIL: LIVE CELL IMAGING CONSUMABLES MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 254 BRAZIL: LIVE CELL IMAGING MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
TABLE 255 BRAZIL: LIVE CELL IMAGING MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION)
TABLE 256 BRAZIL: LIVE CELL IMAGING MARKET, BY END USER, 2021–2028 (USD MILLION)
10.5.2 REST OF LATIN AMERICA
TABLE 257 REST OF LATIN AMERICA: LIVE CELL IMAGING MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION)
TABLE 258 REST OF LATIN AMERICA: LIVE CELL IMAGING INSTRUMENTS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 259 REST OF LATIN AMERICA: LIVE CELL IMAGING CONSUMABLES MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 260 REST OF LATIN AMERICA: LIVE CELL IMAGING MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
TABLE 261 REST OF LATIN AMERICA: LIVE CELL IMAGING MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION)
TABLE 262 REST OF LATIN AMERICA: LIVE CELL IMAGING MARKET, BY END USER, 2021–2028 (USD MILLION)
10.5.3 LATIN AMERICA: RECESSION IMPACT
10.6 MIDDLE EAST & AFRICA
10.6.1 GROWING PHARMACEUTICAL INDUSTRY TO DRIVE MARKET GROWTH
TABLE 263 MIDDLE EAST & AFRICA: LIVE CELL IMAGING MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION)
TABLE 264 MIDDLE EAST & AFRICA: LIVE CELL IMAGING INSTRUMENTS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 265 MIDDLE EAST & AFRICA: LIVE CELL IMAGING CONSUMABLES MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 266 MIDDLE EAST & AFRICA: LIVE CELL IMAGING MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
TABLE 267 MIDDLE EAST & AFRICA: LIVE CELL IMAGING MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION)
TABLE 268 MIDDLE EAST & AFRICA: LIVE CELL IMAGING MARKET, BY END USER, 2021–2028 (USD MILLION)
10.6.2 MIDDLE EAST & AFRICA: RECESSION IMPACT
11 COMPETITIVE LANDSCAPE
11.1 INTRODUCTION
11.2 STRATEGIES ADOPTED BY KEY PLAYERS
FIGURE 32 LIVE CELL IMAGING MARKET: STRATEGIES ADOPTED BY KEY PLAYERS
11.3 REVENUE SHARE ANALYSIS
FIGURE 33 REVENUE ANALYSIS OF KEY PLAYERS, 2020–2022
11.4 MARKET SHARE ANALYSIS
FIGURE 34 MARKET SHARE ANALYSIS OF KEY PLAYERS, 2022
TABLE 269 LIVE CELL IMAGING MARKET: DEGREE OF COMPETITION
11.5 COMPANY EVALUATION QUADRANT: KEY PLAYERS
FIGURE 35 LIVE CELL IMAGING MARKET: COMPANY EVALUATION MATRIX FOR KEY PLAYERS, 2022
11.5.1 STARS
11.5.2 EMERGING LEADERS
11.5.3 PERVASIVE PLAYERS
11.5.4 PARTICIPANTS
11.6 COMPETITIVE BENCHMARKING OF TOP 25 PLAYERS
11.6.1 END-USER FOOTPRINT OF COMPANIES (25 COMPANIES)
TABLE 270 END-USER FOOTPRINT ANALYSIS OF KEY PLAYERS IN LIVE CELL IMAGING MARKET
11.6.2 PRODUCT & SERVICE FOOTPRINT OF COMPANIES (25 COMPANIES)
TABLE 271 PRODUCT & SERVICE FOOTPRINT ANALYSIS OF KEY PLAYERS IN LIVE CELL IMAGING MARKET
11.6.3 REGIONAL FOOTPRINT OF COMPANIES (25 COMPANIES)
TABLE 272 REGIONAL FOOTPRINT ANALYSIS OF KEY PLAYERS IN LIVE CELL IMAGING MARKET
11.7 COMPANY EVALUATION QUADRANT: START-UPS/SMES
FIGURE 36 LIVE CELL IMAGING MARKET: COMPANY EVALUATION MATRIX FOR START-UPS/SMES, 2022
11.7.1 PROGRESSIVE COMPANIES
11.7.2 STARTING BLOCKS
11.7.3 RESPONSIVE COMPANIES
11.7.4 DYNAMIC COMPANIES
11.8 COMPETITIVE BENCHMARKING OF START-UP/SME PLAYERS
TABLE 273 LIVE CELL IMAGING MARKET: DETAILED LIST OF KEY START-UP/SME PLAYERS
TABLE 274 LIVE CELL IMAGING MARKET: COMPETITIVE BENCHMARKING OF START-UP/SME PLAYERS
11.9 COMPETITIVE SCENARIO AND TRENDS
11.9.1 PRODUCT LAUNCHES
TABLE 275 LIVE CELL IMAGING MARKET: PRODUCT LAUNCHES, JANUARY 2020–DECEMBER 2022
11.9.2 DEALS
TABLE 276 LIVE CELL IMAGING MARKET: DEALS, JANUARY 2020–DECEMBER 2022
11.9.3 OTHER DEVELOPMENTS
TABLE 277 LIVE CELL IMAGING MARKET: OTHER DEVELOPMENTS, JANUARY 2020–DECEMBER 2022
12 COMPANY PROFILES
12.1 KEY COMPANIES
(Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats))*
12.1.1 DANAHER
TABLE 278 DANAHER: BUSINESS OVERVIEW
FIGURE 37 DANAHER: COMPANY SNAPSHOT (2022)
12.1.2 ZEISS GROUP
TABLE 279 ZEISS GROUP: BUSINESS OVERVIEW
FIGURE 38 ZEISS GROUP: COMPANY SNAPSHOT (2022)
12.1.3 SARTORIUS AG
TABLE 280 SARTORIUS AG: BUSINESS OVERVIEW
FIGURE 39 SARTORIUS AG: COMPANY SNAPSHOT (2022)
12.1.4 THERMO FISHER SCIENTIFIC, INC.
TABLE 281 THERMO FISHER SCIENTIFIC, INC.: BUSINESS OVERVIEW
FIGURE 40 THERMO FISHER SCIENTIFIC, INC.: COMPANY SNAPSHOT (2022)
12.1.5 OLYMPUS CORPORATION
TABLE 282 OLYMPUS CORPORATION: BUSINESS OVERVIEW
FIGURE 41 OLYMPUS CORPORATION: COMPANY SNAPSHOT (2022)
12.1.6 PERKINELMER INC.
TABLE 283 PERKINELMER INC.: BUSINESS OVERVIEW
FIGURE 42 PERKINELMER INC.: COMPANY SNAPSHOT (2023)
12.1.7 NIKON CORPORATION
TABLE 284 NIKON CORPORATION: BUSINESS OVERVIEW
FIGURE 43 NIKON CORPORATION: COMPANY SNAPSHOT (2022)
12.1.8 ETALUMA, INC.
TABLE 285 ETALUMA, INC.: BUSINESS OVERVIEW
12.1.9 CYTOSMART TECHNOLOGIES
TABLE 286 CYTOSMART TECHNOLOGIES.: BUSINESS OVERVIEW
12.1.10 AGILENT TECHNOLOGIES, INC.
TABLE 287 AGILENT TECHNOLOGIES, INC.: BUSINESS OVERVIEW
FIGURE 44 AGILENT TECHNOLOGIES, INC.: COMPANY SNAPSHOT (2022)
12.1.11 NANOENTEK INC.
12.1.12 BECTON, DICKINSON AND COMPANY
TABLE 288 BECTON, DICKINSON AND COMPANY: BUSINESS OVERVIEW
FIGURE 45 BECTON, DICKINSON AND COMPANY: COMPANY SNAPSHOT (2022)
12.1.13 GE HEALTHCARE
TABLE 289 GE HEALTHCARE: BUSINESS OVERVIEW
FIGURE 46 GE HEALTHCARE: COMPANY SNAPSHOT (2022)
12.1.14 BRUKER CORPORATION
TABLE 290 BRUKER CORPORATION: BUSINESS OVERVIEW
FIGURE 47 BRUKER CORPORATION: COMPANY SNAPSHOT (2022)
12.1.15 MERCK KGAA
TABLE 291 MERCK KGAA: BUSINESS OVERVIEW
FIGURE 48 MERCK KGAA: COMPANY SNAPSHOT (2022)
12.1.16 BIO-RAD LABORATORIES, INC.
TABLE 292 BIO-RAD LABORATORIES, INC.: BUSINESS OVERVIEW
FIGURE 49 BIO-RAD LABORATORIES, INC.: COMPANY SNAPSHOT (2022)
12.1.17 CORNING INCORPORATED
TABLE 293 CORNING INCORPORATED: BUSINESS OVERVIEW
FIGURE 50 CORNING INCORPORATED: COMPANY SNAPSHOT (2022)
12.2 OTHER PLAYERS
12.2.1 BLUE-RAY BIOTECH CORP.
12.2.2 CYTENA GMBH
12.2.3 NANOLIVE SA
12.2.4 ABBERIOR
12.2.5 PHASE HOLOGRAPHIC IMAGING PHI AB
12.2.6 CYTOSKELETON, INC.
12.2.7 KEYENCE CORPORATION
12.2.8 ALIGNED GENETICS, INC.
*Details on Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats) might not be captured in case of unlisted companies.
13 APPENDIX
13.1 DISCUSSION GUIDE
13.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
13.3 CUSTOMIZATION OPTIONS
13.4 RELATED REPORTS
13.5 AUTHOR DETAILS
